<!doctype html>
<html lang="en">

<head>
  <meta charset="utf-8">
  <meta name="viewport" content="width=device-width, initial-scale=1">

  <link
    crossorigin="anonymous"
    href="https://cdnjs.cloudflare.com/ajax/libs/bootstrap/5.1.3/css/bootstrap.min.css"
    integrity="sha512-GQGU0fMMi238uA+a/bdWJfpUGKUkBdgfFdgBm72SUQ6BeyWjoY/ton0tEjH+OSH9iP4Dfh+7HM0I9f5eR0L/4w=="
    referrerpolicy="no-referrer"
    rel="stylesheet"
  />
  <link rel="stylesheet" href="./static/css/oxford.css">
  <link rel="stylesheet" href="./static/css/outliers.css">

  <title>Static outliers for NHS South East London CCG</title>
</head>
<body>
    <div class="bg-dark">
      <div class="container d-flex justify-content-center">
        <a class="visually-hidden-focusable text-white p-2" href="#content">Skip to main content</a>
      </div>
    </div>

    <header>
      <nav class="navbar navbar-expand-lg navbar-dark bg-dark bg-oxford">
        <div class="container">
          <a class="navbar-brand" href="../index.html">OpenPrescribing outlier detection</a>
        </div>
      </nav>
    </header>

    <main id="content">
      <div class="bg-oxford-50 mb-4">
        <div class="container pt-5 pb-4">
          <div class="row">
            <div class="col-12">
              <h1 class="display-5 fw-bold lh-1">Static outliers for NHS South East London CCG</h1>
            </div>
            <div class="col-lg-8 col-md-9 col-12 pt-4 fs-5">
              <p>There is substantial variation in prescribing behaviours, across various different areas of medicine. Some variation can be explained by demographic changes, or local policies or guidelines, but much of the remaining variation is less easy to
                explain. At <a href="https://openprescribing.net/">OpenPrescribing</a> we are piloting a number of data-driven approaches to identify unusual prescribing and collect feedback on this prescribing to inform development of new tools to support
                prescribers and organisations to audit and review prescribing.</p>
              <div class="collapse" id="explainerTextCollapse">
                <p>This report has been developed to automatically identify prescribing patterns at a chemical level which are furthest away from “typical prescribing” and can be classified as an “outlier”. We calculate the number of prescriptions for each chemical
                    in the <a href="https://www.thedatalab.org/blog/161/prescribing-data-bnf-codes">BNF coding system</a> using the BNF subparagraph as a denominator, for prescriptions dispensed between June 2021 and December 2021. We then calculate the
                    mean and standard deviation for each numerator and denominator pair across all practices/CCGs/PCNs/STPs. From this we can calculate the “z-score”, which is a measure of how many standard deviations a given practice/CCG/PCN/STP is from the
                    population mean. We then rank your “z-scores” to find the top 5 results where prescribing is an outlier for prescribing higher than its peers and those where it is an outlier for prescribing lower than its peers.
                </p>
                <p>It is important to remember that this information was generated automatically and it is therefore likely that some of the behaviour is warranted. This report seeks only to collect information about where this variation may be warranted and where
                    it might not. Our full analytical method code is openly available on GitHub <a href="https://github.com/ebmdatalab/outliers/">here</a>.
                </p>
                <p>The DataLab is keen to hear your feedback on the results. You can do this by completing the following <a href="https://docs.google.com/forms/d/e/1FAIpQLSeH4ai_qyetAY4UAgZSWGnYQHkXNr9efFBmQvdrBi5uuXvgnQ/viewform?usp=pp_url&entry.2016356131=ccg+72Q">survey</a>            or emailing us at <a href="mailto:ebmdatalab@phc.ox.ac.uk?subject=OpenPrescribing%20outliers%20feedback">ebmdatalab@phc.ox.ac.uk</a>. Please DO NOT INCLUDE IDENTIFIABLE PATIENT information in your feedback. All feedback is helpful, you can
                    send short or detailed feedback.
                </p>
              </div>
              <p>
                <button id="explainerTextBtn" class="btn btn-link p-0" type="button" data-bs-toggle="collapse" data-bs-target="#explainerTextCollapse" aria-expanded="false" aria-controls="explainerTextCollapse">
                  Show more &plus;
                </button>
              </p>
            </div>
          </div>
        </div>
      </div>
    </main>

    <section aria-labelledby="higherHeading">
      <div class="container">
        <h2 class="pb-3" id="higherHeading">Prescribing where NHS South East London CCG is higher than most</h2>
        <button id="higherHeading-lowShowHide" class="btn btn-outline-danger-outline mb-3" type="button">Hide low numbers</button>
      </div>
      <div class="container mb-4">
        <div class="table-responsive">
          <table border="1" class="dataframe table table table-sm table-bordered" id="table_high">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="Standard Deviation">std</abbr></th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr class="low_number row_1">
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0402010AG&amp;denomIds=4.2.1&amp;selectedTab=summary">Ziprasidone hydrochloride</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_high_0_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>4</td>
      <td>Antipsychotic drugs</td>
      <td>172796</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>10.20</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_arw0HipREVPSJq2RItGIrIxoKABwWMJ"><img width="250" class="h-auto" src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAg0AAACWCAYAAABdJrs9AAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAAXEQAAFxEByibzPwAAADh0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uMy4xLjMsIGh0dHA6Ly9tYXRwbG90bGliLm9yZy+AADFEAAAMEUlEQVR4nO3de8xkdX3H8feP3SUUEPCSqHVtTlwuASoCKYoJVSFtbThCNBLkUmCN9dLQarw0Hi+pREVPSJq2RItGIrIxoKABwWMJIVpsUCNCKAoYXPBEWMUL4oXNLizL8Y/5PTr77O337M4zv3Nm3q/kZObMnJn97Pc52eezc2bOhK7rkCRJ2p19cgeQJEnDYGmQJElJLA2SJCmJpUGSJCWxNEiSpCSWBkmSlMTSIEmSklgaJElSEkuDJElKYmmQJElJLA2SJCmJpUGSJCWxNEiSpCSWBkmSlMTSIEmSklgaJElSEkuDJElKYmmQJElJLA2SJCmJpUGSJCWxNEiSpCSWBkmSlMTSIEmafSEcQAhdXA7IHWeoLA2SJCnJytwB9lZRNW8DNgB3tXX5UO48kiTNqll4peEy4AbggaJqTskdRpKkWTULpeGDwDpgFfDlomoOz5xHkqSZFLquy51hIoqqqYH3AuuBE9u6fDRzJElSX4ze/Ph4XDuQrtuYM85QzcIrDQveD1wPHMroFYd9M+eRJGmmzExpaOvyaeAfgDuBVwL/nTeRJEmzZWYOTywoquYFwO3A84GXtXX53cyRJEm5eXhiImbmlYYFbV1uAD4UVz+QM4skSbNk5kpDtA54GDi9qJpjcoeRJGkWzGRpaOvyCeCSuPr+nFkkSZoVM1kaosuBXwBnFlVzRO4wkiQN3cyWhrYuNwH/DgSgyhxHkqTBm9nSEF0GPAacV1RNkTmLJEmDNtOloa3L3wP/BaxgdLZISZK0h2a6NESXMvps7tqiag7OHUaSpKGa+dLQ1uVjwBeB/YA3ZI4jSdJgzXxpiK6Il2/MmkKSpAGbl9LwLeB+4MSiao7MHUaSpCGai9LQ1mUHfC6urs2XRJKk4ZqL0hCtA54Gzi+qZmXuMJIkDc3clIb4RVY3A88DXp05jiRJgzM3pSHyDZGSJO2heSsNNzA6Q+TpRdU8J3cYSZKGZK5KQ1uXm4GrgFXAuZnjSJI0KHNVGqKFQxQXZE0hSdLAzGNpuBO4FzjOczZIkpRu7kpDPGfDVXH17JxZJEkakrkrDdHV8fKcompC1iSSJA3EXJaGti4fBL4DrAFOyBxHkqRBmMvSEC0cojgnawpJkgZinkvDNYxOK31WUTUrcoeRJKnv5rY0tHX5c+AW4LnAyZnjSJLUe3NbGiIPUUiSlGjeS8N1wBPA64uq2S93GEmS+myuS0Nbl78DbgQOAk7NHEeSpF6b69IQLRyi8LsoJEnaBUsDfA34DfCaomqelTuMJEl9Nfeloa3LJ4AvAPsCZ2aOI0lSb819aYjWxcvzs6aQJKnHLA0j3wHWAy8vquaw3GEkSeojSwN//ObLhVcbzsuZRZKkvrI0/Mnn4+V5RdU4F0mSFvGXY9TW5Y+BbwIFcFLeNJIk9Y+lYVu+IVKSpJ2wNGzrS8Bm4MyiavbPHUaSpD6xNIxp6/K3wPXAM4DXZo4jSVKvWBq2d2W8fHPWFJIk9YylYXs3Aw8Cryqq5i9zh5EkqS8sDYu0dfk08Mm4emHOLJIk9YmlYceuADYB5xdVc0juMJIk9YGlYQfaunyM0cme9gcuyBxHkqResDTs3Cfi5YWeIVKSJEvDTrV1eTejM0QeBvxd5jiSJGVnadi1hVcb/jlrCkmSesDSsGvXAz8FTi2qZk3uMJIk5WRp2IW2LrcAnwIC8K+Z40iSlJWlYfc+AfwGeFNRNYfmDiNJUi6Wht2IH7+8BFgJfDhzHEmSsrE0pLkU+DlwdlE1x+YOI0lSDpaGBG1dbgQ+ElcvzplFkqRcLA3pPgP8mNEnKU7KHUaSpGmzNCRq6/JJ4N/i6seLqgk580iSNG2WhqW5GvgBcBJwRuYskiRNlaVhCdq63Aq8M65+uqia1TnzSJI0TZaGJWrr8hbgP4FnAuuKqlmROZIkSVNhadgz7wPuBk4G3pM5iyRJUxG6rsudYZCKqjkKuIPRSZ9ObOvyjsyRJEk7E8IBwONx7UC6bmPOOEPlKw17qK3Le4F3MyoNVxVVc0jmSJIkLStLw965DLgROBz4elE1z8mcR5KkZWNp2AttXXbAOcA3gOOA/y2q5nl5U0mStDwsDXuprcvHgRK4CTgauNWPYkqSZpGlYQLautwEvBb4CqNDFbcVVfO3eVNJkjRZfnpigoqqWQVcAZwbb7oaeFdbl4/kSyVJ8tMTk2FpmLD4nRSvY/R12i8Afgt8GPhcW5e/zplNkuaWpWEiLA3LpKiaZzAqC29ndBjoSUaftLgSuKmtyy0Z40nSfLE0TISlYZkVVfNi4J+As4GFczlsAu4EvgvcDtwHPAw8Gj+RIUlagnhK/1XAvvFym+vHbfjh/td9/j13AJxx7iXHfm/1URuBbmx5CtgSLxcvW/23ecTSMCVF1ewHnAacB7wCOHgHm20GNgCPAr+Ly++BJxjtzAvLU4uuL/4hLmV9qY9diqV+ffhybt+nLH3bvk9Z+rZ9n7L0bfs9ee6V/OkX+uJf8LtbFm+7uBzsMs+fPbmZ+/5j9OXER77zS2zad78lxt+uSOysYOzo9uRt27r8l6UGm6aVuQPMi7YuNwPXAtcWVbMPcCjwUuAE4EXAC4HVwJq4SJK21zE63LvwH6eNY9ef3Mn1LSu7rfsAfwOwotv69fg8+zAqGwuFZkfLqp3cfuDY/ZPU69Iw6FcaQgj3AHRdd3TuLLPEuU6eM10eznV5ONflMQtz9TwNkiQpiaVBkiQlsTRIkqQklgZJkpTE0iBJkpJYGiRJUpJBf+RSkiRNj680SJKkJJYGSZKUxNIgSZKSWBokSVISS4MkSUpiaZAkSUmmUhpCCK8KIdwTQlgfQrg8hLBiB9ucGUK4P4TwQAjh4rHbDwoh3BhC+FEI4XshhCOn/Zi+GshcLwoh/CyEcFdcPrA805icns31mhDCL0MI6xf9+StDCFfEjPeEEP568pOYnIHMdG0I4dGxffWTk5/EZPVlriGEY0MIt8UsPwghvH3sMYPaV2Ewc82zv3Zdt6wLo2KyHjgqrl8DXLBom4OBnwDPZ/T95N8CXhnv+yjwsXj9VOAb03xMX5cBzfUi4IO55zXEucb1U4DjgfWLMvwjcFW8fgxwP/G8K31bBjTTtcDluec1xLkChwNHxOsHAT8Cjh3avjqwuWbZX6fxA3gZ8M2x9VcDNyza5g3AurH1twKXxuv3AS8au28D8OxpPSb3DjwDc72IYZWG3sx1bL1g+19w/wOcMrb+beD43PMb+EzXMqzS0Lu5jt1+A3Da0PbVgc01y/46jcMTq4GHxtZ/ArxwCdssvu/heNu0HtNXQ5krwFtCCHeHEK4LIRy2679Wdn2a697m7IuhzBTgtBDC/4cQbg4hnJCwfU69nGsIYQ3wV8BtS8jZJ0OZK2TYX6dRGsKEtsn1mL4aylw/Bazpuu4Y4AvAjXvw/NPUp7lO8/mW01Bm+lWg6LruJcDFwHUhhAMn/GdMUu/mGkI4BLgeeEfXdb/e2+fLZChzzbK/TqM0PMS2Le0vGLWo1G0eXnTfakYv3UzrMX01iLl2XfdI13Vb4vUvAoeEEJ69+79eNn2a697m7ItBzLTrul91XbcpXr81PscRu3pMZr2aawhhf6ABPtN13bVLzNkng5hrtv11CseHVgAPsu2bSt64aJuDGQ10/A0iJ8f7LmbbN4jcOs3H9HUZ0Fz/fCzPyXG7Pr8JqjdzHfvzCrY//v5mtn1z2fq+znVAMx3fV48GHgGemXt+Q5grsAq4CbhoBzkHs68ObK5Z9tdp/RBOAe4FHgA+Gwd2OmNv4gDOYvTO0AeAjy/64Xw13ncncPS0H9PXZSBzXQd8H7gL+D/ghNxzG9hcG+BnwFOM/ifxvnj7KuBKRv8A30t8F3Zfl4HM9GPAPXFfvR34+9xzG8pcgXOBrXF2C8sZQ9xXBzTXLPurX40tSZKSeEZISZKUxNIgSZKSWBokSVISS4MkSUpiaZAkSUksDZIkKYmlQZIkJbE0SJKkJJYGSZKUxNIgSZKSWBokSVISS4MkSUpiaZAkSUksDZIkKYmlQZIkJbE0SJKkJJYGSZKUxNIgSZKSWBokSVISS4MkSUpiaZAkSUksDZIkKYmlQZIkJbE0SJKkJH8AEOYxrF+tnoEAAAAASUVORK5CYII="></button><div class="modal fade" id="plot_arw0HipREVPSJq2RItGIrIxoKABwWMJ" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
    <tr id="table_high_0_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0402010AGAAAAAA&amp;denomIds=4.2.1&amp;selectedTab=summary" target="_blank">Ziprasidone 40mg capsules : 4</a></li></ul></td></tr><tr class="row_2">
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0404000E0&amp;denomIds=4.4&amp;selectedTab=summary">Caffeine citrate</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_high_1_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>15</td>
      <td>CNS Stimulants and drugs used for ADHD</td>
      <td>29691</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>10.20</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_grWKmWhrNrTqsW1AkxZBCoCxdU0Ia2O"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_grWKmWhrNrTqsW1AkxZBCoCxdU0Ia2O" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAg0AAACWCAYAAABdJrs9AAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAAXEQAAFxEByibzPwAAADh0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uMy4xLjMsIGh0dHA6Ly9tYXRwbG90bGliLm9yZy+AADFEAAAMBUlEQVR4nO3df6wlZX3H8fezdxeh2LWGmIgITmLBuivUXyBRGys1FT0pMUGKJesPUCRogrWKmWhrNrTqsW1AkxZ/BCoCxdU0Ia2OGjRSirZWcIM/djX80KmC+AM1ioiwe3n6xzxbLrd34dl7zz3PmTnvVzI5d86Zc+53vnfuPZ8z89yZEGNEkiTpkWwoXYAkSeoHQ4MkScpiaJAkSVkMDZIkKYuhQZIkZTE0SJKkLIYGSZKUxdAgSZKyGBokSVIWQ4MkScpiaJAkSVkMDZIkKYuhQZIkZTE0SJKkLIYGSZKUxdAgSZKyGBokSVIWQ4MkScpiaJAkSVkMDZIkKYuhQZIkZTE0SJKkLIYGSZIeSQiHEkJM06GlyynF0CBJkrJsLF1AjqpuzgPuBFrgxnY8imUrkiRp/vRlT8P7gU8AXwE+XNVNKFyPJElzpy+h4W3ARXR7G14HbC9ajSRJcyjE2J89/VXdHAdcD2wGzmnHow8XLkmSNA+6wY+/SnOPJsZ7SpZTSl/2NADQjkdfB14G7AE+UNXNKYVLkiRpbvQqNAC049G1wKvoat9R1c0JhUuSJGku9C40ALTj0Q7grcAhwMUOjJQkaf31MjQkFwJfBZ4FeJhCkqR11tvQkM7V8M40e0FVN71dF0mS+qDvb7SfAb4MHAecWrgWSZIGrdehYdnehu1V3SyUrEeSpCHrdWhIPk937oYtwOmFa5EkabB6HxrS3oa/SrPbq7rpxfU0JEnqm96HBoB2PLoO+AJwNLCtcDmSJA3SIEJDsm9sw1s8b4MkSZM3mNDQjkdfojtvw9OAEwuXI0nS4AwmNCT7LmB1TtEqJEkaoKGFho/RXYXs9KpuHlu6GEmShmRQoaEdj+4GrgIOxgGRkiRN1KBCQ/KhdPt6B0RKkjQ5gwsN7Xi0EwdESpI0cYMLDcm+vQ0OiJQkaUKGGhp24IBISZImapChIQ2I/GccEClJ0sQMMjQk+87ZcLYDIiVJWrvBhoY0IPIm4Fjg6YXLkSSp9wYbGpKPpttXF61CkqQBGHpouArYC5xR1c2m0sVIktRngw4N7Xj0Y+AzwOOAlxQuR5KkXht0aEg8RCFJ0gTMQ2j4FPBz4E+qujmsdDGSJPXV4ENDOx7dR3f1y03AnxUuR5Kk3hp8aEg8RCFJ0hrNS2i4Afg28OyqbraULkaSpD6ai9DQjkcR9zZIkrQmcxEakiuBCLyyqpuNpYuRJKlv5iY0tOPR7cA1wOHAyYXLkSSpd+YmNCSXptvXFq1CkqQemrfQ8G/AXXTnbHh86WIkSeqTuQoN6ZwNVwALwKsKlyNJUq/MVWhI/u8QRVU3oWglkiT1yNyFhnY82gV8GTgGeF7hciRJ6o25Cw3Jvr0NrytahSRJPTKvoeHjwD3AaVXdbC5djCRJfTCXoaEdj+6mCw6/BbyicDmSJPXCXIaGxEMUkiQdgHkODf8F7AaOr+rmhNLFSJI06+Y2NKSLWL0/zb65ZC2SJPXB3IaG5Argp3QDIo8qXYwkSbNsrkNDOx7dC1xMd4bI8wqXI0nSTJvr0JD8I3A/cLb/filJ0v7NfWhox6MfAVcCm4GzCpcjSdLMmvvQkFyUbt9U1c3GopVIkjSjDA1AOx59E7gGqICXla1GkqTZZGh40IXp9i1Fq5AkaUYZGh50DbALOLGqmz8uXYwkSbPG0JCkkz29M83+fVU3CyXrkSRp1hgaHupq4HrgWODMwrVIkjRTQoyxdA0zpaqb44GvAD8Ejm7Ho18VLkmSVFoIhwL73g8eTYz3lCynFPc0LNOORzcAVwGPB84vXI4kSTPD0LCytwP3AedXdXNE6WIkSZoFhoYVtOPR/wDvAw4B/rpwOZIkzQRDw/69B7gLeE1VN88vXYwkSaUZGvajHY9+AbwVCMCOqm4eV7gkSZKKMjQ8vMvTdARwRVU39kuSNLd8E3wY6YRPbwB2Ay8G6rIVSZJUjudpyFDVzRbgBuBg4KR2PLqucEmSpGnyPA2AexqytOPRbuBcun59rKqbIwuXJEnS1BkaMrXj0eXApcDhwJequvm9wiVJkjRVhoYDcy5wBXAk8MWqbp5TuB5JkqbG0HAA2vFoD/Aa4ELgMOALVd28uGhRkiRNiQMhV6Gqm0B3XYr3AnuBC4C/a8ej3xQtTJK0PhwICRga1qSqm7OADwAHAd8F/gL41/SvmpKkoTA0AIaGNavq5sl0hytOSXd9DhgD17Xj0WKxwiRJk2NoAAwNE1PVzcl0F7l6SrrrB8AOusts73TvgyT1mKEBMDRMVFU3BwFnANuAk+iuWwHwM2An8NV0ezNwB/DTdjx6oECpkqSkqpsFusPMm/YzbXjGHd86+Oorz98JcNoZ7/39G47c+msgpukBuvFt+5sWh/LB0dCwTqq6ORw4HTgNeBbwqBUW20O3R+Iu4G7gl+n23vTY3v3cLtJtqEut9/yBCo+8yJqW93v4Pfwe8/E9NvDgm/dG/v8b+kr3Pdz9K02PWNch9/+Gb130cgCe+uZ/4d6DDj7Q9VhkhTCxwn0Tmdrx6E0HWmCOjevxooJ2PLqT7nDF+6q62QRsoQsPzwSeRHcRrCPS108qVackzZFFug9ee4D76A437Fky3b9sft+0uDEubgReBLAQF6+l+2AV0rQBWKB7T82ZFug+SC69b9LWJTTM/J6GEMIugBjj1tK19J29nBx7OTn2cnLs5eTYy5V5cidJkpTF0CBJkrIYGiRJUhZDgyRJymJokCRJWQwNkiQpy8z/y6UkSZoN7mmQJElZDA2SJCmLoUGSJGUxNEiSpCyGBkmSlMXQIEmSskwlNIQQ/jCEsCuEcGsI4ZIQwsIKy/xpCOHmEMJtIYR3Lbl/cwjhkyGEW0IIN4YQnrqW5/RdgV6+JIRwUwhhbwhh2/qv4fQU6OXfhhC+HUL4WgjhcyGEwVwSvUAv3xhC+HraNm8MIbxg/ddyOqbdyyWPnxhCWBzS73mB7XJ7COHOtF3eFEJ4x/qv5ZTFGNd1ogsmtwJb0vwngFcvW+YxwPeAw+muK/6fwAvSY38DvDt9/VLg2tU+p+9ToV7+LvA04HJgW+ke9LyXJwOb0tfnAleX7kOPe7l5yWs/HWhL96GvvUyPHwT8B9AM5fe80Ha5HfjL0uu+ntM09jQcD/wgxrg7zV8KnLpsmZOBf48x3hlj3At8dMkypwKXAMQYPw0cE0I4bJXP6bup9zLGeGuM8ZvAA+u4XiWU6OVnY4x70vP/GzhqfVZt6kr08pdLXvtQYChnqSvx9xLg7cBlwE8mv0rFlOrloE0jNDwR+P6S+e8BRx7AMssfuz3dt5rn9F2JXg5V6V6eA3z6gKueTUV6GUI4M4RwM/BJ4JVrqH+WTL2XIYStwHOBj6yx9llT6nf89enQ2dUhhKNXX/5smkZoCBNaZhLP6Tt7OTnFehlCOBt4BvDuVbz+LCrSyxjjR2KMxwDbgAtW8fqzaKq9DCFsAC4Gzotp//qAlNguPwg8OcZ4HLCDLtAOyjRCw/d5aAo7ii6x5S5z+7LHngjcscrn9F2JXg5VkV6GEE4F/hwYxRjvXUP9s6Todpl2HR8bQnjsaoqfMdPu5W8DW4HPhhBa4OXARSGEs9a0FrNh6ttljPGH+w5Bxhg/DvzOQA6NP2i9B00AC8B3eOhglDOXLfMYuh/E0oElL0yPvYuHDka5brXP6ftUopdLXvcyBjJAquB2+SLgFuCo0us/gF4+Zclr/wFwe+k+9LWXy157ML/nhbbLJyx57Rem5ULpXky0r1P64Z0E7AZuA/4pNfoU4JIly7wi/UG9DXjPsh/qp9JjO4Gta3lO36cCvfwjuhR9D/Cz9PWjSvehp728he6Tyk1p+nzpHvS4l/8A7Ep9/CJwQuke9LWXy773ZQwkNBTaLi8HvpG2y+uB40v3YNKTl8aWJElZPCOkJEnKYmiQJElZDA2SJCmLoUGSJGUxNEiSpCyGBkmSlMXQIEmSshgaJElSFkODJEnKYmiQJElZDA2SJCmLoUGSJGUxNEiSpCyGBkmSlMXQIEmSshgaJElSFkODJEnKYmiQJElZDA2SJCmLoUGSJGUxNEiSpCyGBkmSlMXQIEmSshgaJElSlv8FMAiuL1MTBeUAAAAASUVORK5CYII="></div></div></div></div></td>
    </tr>
    <tr id="table_high_1_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0404000E0AAAKAK&amp;denomIds=4.4&amp;selectedTab=summary" target="_blank">Caffeine citrate 50mg/5ml oral solution : 15</a></li></ul></td></tr><tr class="row_3">
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0504010L0&amp;denomIds=5.4.1&amp;selectedTab=summary">Mefloquine hydrochloride</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_high_2_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>54</td>
      <td>Antimalarials</td>
      <td>30761</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>7.92</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_4q3MhSBx1wpHzQHFe9BINEYNeKHE4xVJ"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_4q3MhSBx1wpHzQHFe9BINEYNeKHE4xVJ" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAg0AAACWCAYAAABdJrs9AAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAAXEQAAFxEByibzPwAAADh0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uMy4xLjMsIGh0dHA6Ly9tYXRwbG90bGliLm9yZy+AADFEAAAQLElEQVR4nO3de5QkZX2H8eeF3QXcXSAICIpYwQsQElQUDQonAfFCKuIxeMEIEeKFaBIP4q3MhSBx1wpHzQHFe9BINEYNeKHE4xVJiHoicguIsEABKiAYQCDA7uxW/qgaqW1mdmtmu/udmn4+57yn69Jd/XvnnZr+TnV1daiqCkmSpM3ZKnYBkiSpHwwNkiSpE0ODJEnqxNAgSZI6MTRIkqRODA2SJKkTQ4MkSerE0CBJkjoxNEiSpE4MDZIkqRNDgyRJ6sTQIEmSOjE0SJKkTgwNkiSpE0ODJEnqxNAgSZI6MTRIkqRODA2SJKkTQ4MkSerE0CBJkjoxNEiSpE4MDZIkqRNDgyRJmxPCckKomrY8djmxGBokSVInS2IXMB9JVjwDOADYEdihuf0V8KEyT8uIpUmStGiFqqpi1zBnSVbMVvQU8ElgdZmnN4yvIknSola/JXFvM7eCqrovZjmx9DU03AacCdwB3AXcDRwInEh95GEK+BTwtjJPfxmrTknSImFoAPobGnYq8/R/Z1i+I/BG4E3Ub1lcARxe5ukvxlyiJGkxMTQAPQ0Nm5NkxQ7A54HnAlcDzynz9Odxq5Ik9ZahAVikn54o8/Ru4EjgPGAf4MIkK/aMW5UkSf22KEMDQJmnDwBHAecAj6cODnvFrUqSpP5atKEBoMzTtcDLgX8FHgecl2TFirhVSZLUT4s6NACUeToFHAucD+wLfDjJihC3KkmS+mfRhwaAMk/XUweHm4FXAq+LW5EkSf0zEaEBoLlew8uAdcAZSVYcELkkSZJ6ZWJCA0CZp98H3gosA77QXNdBkiR1MFGhoXEG8O/AbwJneX6DJEndTFxoKPO0Al4NXA+8GPjjuBVJktQPExca4NcXfzq+mT0jyYrdYtYjSVIfTGRoACjz9ELgA8BOza0kSdqEiQ0NjXcAJXBUkhUvjVyLJEkL2kSHhjJP7wVe08yemWTFLjHrkSRpIZvo0ABQ5um3gI8CuwCnRy5HkqQFa+JDQ+NtwE+BVyRZ8cLYxUiStBAZGvj1pylOaGY/mGTF9jHrkSRpITI0NMo8/SrwWWAPYFXkciRJWnAMDRs7EbgT+PMkKw6KXYwkSQuJoaGlzNPbgDcDAfhYkhXLIpckSdKCYWh4uE8C3wb2A94etxRJkhaOUFVV7BoWnCQrngBcQR2qnlzm6dWRS5IkxRTCcuDeZm4FVXVfzHJi8UjDDMo8XQOcQv0V2h9NssKfkyRp4vliOLv3AZcBh/DQVSMlSZpYvj2xCUlWPB34AXAPsG+Zp7dELkmSFINvTwAeadikMk9/SH1p6R2A90cuR5KkqAwNm3cycCP1N2G+KHYxkiTFYmjYjOabMP+smT3TS0xLkiaVoaGDMk+/BnwGeAxwWuRyJEmKwtDQ3YnAHcAJSVYcEbsYSZLGzdDQUZmntwOvbWbPSrJi55j1SJI0boaGOSjz9IvAWcBuwEeSrAiRS5IkaWwMDXN3InAD8EfAn0SuRZKksTE0zFGZp/cAxwIbgPcnWZHErUiSpPEwNMxDmacXAf8ArATOTrJiSeSSJEkaOUPD/J0C/Ag4GFgdtxRJkkbP0DBPZZ6uBV4K3Am8NcmKl0QuSZKkkTI0bIEyT68HXglUwCeSrNg3ckmSJI2MoWELlXl6PvBOYAVwTpIVKyOXJEnSSBgahuPvga8C+1AfcfD6DZKkRcfQMARlnm4AjgGuB44C3hW3IkmShs/QMCRlnt4JvAi4G/irJCv+MnJJkiQNlaFhiMo8/R/gSOBB4PQkK14WuSRJkobG0DBkZZ5eCBxN/YmKs5OsODRySZIkDYWhYQSaL7Z6PbAM+FKSFU+LXJIkSVvM0DAiZZ5+lPqqkSuBbydZcXDciiRJ2jKGhtE6tWnbA19PsuL5keuRJGneQlVVsWtY9JKseDPwHmAdcHSZp+dELkmSNBchLAfubeZWUFX3xSwnFo80jEGZp+8FXgcsAT6fZMWrI5ckSdKceaRhjJKsOBo4mzo8fAA4qczTdXGrkiRtlkcaAI80jFWZp58FngvcAfwF8K0kK3aLW5UkSd0YGsaszNMLgKcBFwOHABcnWfG7UYuSJKkD356IJMmK7YAPAa8Cpqi/r2K1b1dI0gLk2xOARxqiKfP0fuB46otAraW+psMPkqzYP2ZdkiTNxiMNC0CSFU8APgEcTP2xzFOB08o8XRu1MElSzSMNgKFhwUiyYivgjcC7gW2BNcBbgC+XeeogSVJMhgbA0LDgJFnxJOB04AXNom9TfzTzsnhVSdKEMzQAhoYFK8mKI4D3AvtSf2PmZ6hPlLwqamGSNIkMDYChYUFLsmIp9ZUkTwF2pg4P5wCryjy9JGJpkjRZDA2AoaEXkqxYTh0e3grs3iz+BnAmUJR5OhWrNkmaCIYGwNDQK0lWbEv9Mc23A49rFt8MfAT4pzJPb41VmyQtaoYGwNDQS0lWLAFS4A3A85rF66mPPnwa+GKZp/fO8nBJ0lwZGgBDQ+8lWfFE4ATgWGDXZvH9wJeAc4GvlXn6q0jlSdLiYGgADA2LRnP04TnAK4EXAyuaVeuA71CHiPPLPL0hToWS1GOGBsDQsCglWfEI4AjgSOAPgZ1aq28Avgl8C7igzNPbxl+hJPWMoQEwNCx6zRGIg6gDxOHAUwbusga4qGnfA6720xiSNMDQABgaJk6SFbsAh1IHiEOAfQbu8gBwOXBJq13RfMGWJE0mQwNgaJh4SVbsDDwLeDbwDOCpwA4Dd1sPXE0dIK5spn8CXOeXakmaCIYGwNCgAUlWBCChDg/t9ugZ7r4euJ46QEy3a6jPm/hZmafrx1CyJI2eoQEwNKijJCt2pT4fYp+m7d20x8zykCnqC0+VrXZjc/sz4FavJSGpNwwNgKFBWyjJipXAk3goRDyR+mqVCTMfnWi7D7h1hvYL4C7gV8DdA7f3lnm6Ydj92JTma8uXzNIC9XeCbBi4nZ7eADwIrB133ZKGyNAAGBo0Qs1lrx9LHSDabXdgt+Z2xzlutgLuoT5hc90m2npg6820JbMsG2zDso46QDzQ3D44w/z09P9RX6Sr6+1s69aVeepOronTvNW6tGnLBlqXZdP/FASA3e65Y5vvf/C4jwE88w2fPOG2lTuvpf47M0W9b08NTM+0bApY22rr2tN92FcNDYqqCRaPog4R021XYHvqEzJnu92GeiffaghlrG+19s69vjU9U1tPHWKm/7BsNXAbqIPINgNt2+Z2GLVvzgZmDxpr2fQft5mmq020DZtZP9v9xy34nCN9zq22sC3h4S/iS2e53dS6pcPs2HZrH+DH//gSAPZ90xe4f9m2w9z8tHaoWDfL9KbWTU+vL/P09aMocJj/RUlzVubpA9TnOtw4n8c3bx0snaFtzcZhYLBNUe9Y0d4yaK6hMR0g2oFiW2C7pj1iltu5rlsJ7DKenkljt4GHXjQfoD4auXaGNvjiu6nl0/8UVADbTT24hPrLAtlu6sF3379s23XUIWcpDx2VXDpwO7is3WY7wjE9v5KH/pbNx0hCQ++ONIQQrgSoqmq/2LWMmn1dnCaprzBZ/bWvi9ek9Xc24zg8KkmSFgFDgyRJ6sTQIEmSOjE0SJKkTgwNkiSpE0ODJEnqpHcfuZQkSXF4pEGSJHViaJAkSZ0YGiRJUieGBkmS1ImhQZIkdWJokCRJnYwlNIQQfj+EcGUIYU0I4eMhhId91WcI4WUhhGtCCNeFEFa1lm8fQvhKCOHaEMIPQwj7juIxPe7raSGEq0MIl4UQvhFCeFxrXdnUcmnTfqfnfT0lhHBLqz9/PZdaetjfD7f6elUIYSqEsFOzrq9j+7kQwu0hhDUD21oSQvhE83xXhhAOmUstPevrSc3zXR5CuCiE8JTWuguabU2P6/OH2ddI/T0uhPDLVp/ObK377RDCxc32vhhCWNHzvp7c6udlIYQqhPDkZt3Ix3YsqqoaaaMOJmuA32rmPwe8auA+OwA3AbtTf+/4fwG/16x7F7C6mf4D4DujeEyP+/oCYGkz/Xrg3NZzlcAei2hcTwH+Zj619LG/A9s+Bvh6n8e2mT8MOABYM7C91wCfaab3B64BwqjHNlJfDwOWN9NHAJe01l0AHDyKcY3Y3+OAj89Sz38Cz2umTwP+rs99Hdj2wcBPxjW242qjfwJ4JnBha/75wJcH7vNy4FOt+ROAM5rpHwN7tdb9DHjksB/T174ObPsA4OLWfMnoXlhijOspzBwaNltLH/s7sO3zgWP7PLat+YSHv7CcDxzWmv9e8/s80rGN0deBbe8E/LI1fwGjDQ0xxvY4ZggNwKOAm1rzewOX97mvA9v+EPC34xrbcbVxvD2xB3Bza/4m4LFzuM/gup82y4b9mGGI0de2E4CvDiz7SnMobFUIYWmXTnQUq6+vaw7rnhtCeOIcatlS0cY2hLArcBBwzsDz9W1s5/Ocfd1nu5ppn/1Ic2j7AyGElXPYVhex+vvCpk9fDyEcOIdatkS0sW32x5cA/zKwapRjOxbjCA1hSPeJ9Zhhb38kdYcQXgs8FVjdWnxIVVVPBZ5NneLfMo/nnndNHe8zl8d8GHh8VVX7A58FvrIFzzNXMX+PXwGcV1XVfa1lfRzb+Wyvr/vs5jcawhHA8cBJrcXHVFW1H/B0YD3wnmE/7ZDuMxfnAUlVVU8GVgHnNucuLNqxpX474ydVVd3QWjbqsR2LcYSGm9k43e1Jndi63uenA+v2oD5MNOzHDEOMvhJCOAo4EUirqrp/enlVVTc3t/cBHweeNecezW7sfa2q6taqqtY10/8G7BhCeGTHWrZUlLFtHAOc3V7Q07Gdz3P2dZ/dpBDCs4AzqffZ26eXV1U1/bu+jvrw9jDHFSL0t6qqO6b/LlVV9d1mG3vPsK1FMbaNmfbZUY/teIz6/Q9ga+B6Nj4Z5fiB++xAPXjtk1EObdatYuOTUb47isf0uK+HA9cCew48z3Jg+1ZdHwNW9byvj25t+9DmfqFLLX3sb7N+b+DnwNZ9H9vWYxMe/r73a9n4RMg14xjbSH3dH7gBeMrA8iXArq35k4FP9+H3eDP9be+3+wG3Ar/RzF/ExidCvrPPfW1t867pPo5rbMfVxvMk9ZmmVwHXAWc1P8AjaZ0cAxxN/eJ3HfDugQE4r1n3I2C/UTymx329ljr9Xtq0bzbL92rmLweupP5v9BE97+ungCuafv0HcOCmaun72DbrTgXeN7Csz2NbALcAU9T/yb2jWb4U+GfqsHAVrU+QjHpsI/T1G8DtPLTPXgosow6DP2zG9Qrg87ReaHrc39XN7+mlwH8DL2g9Zn/gkmZ7XwZW9rmvzbo/Bc4ZqGMsYzuO5ldjS5KkTrwipCRJ6sTQIEmSOjE0SJKkTgwNkiSpE0ODJEnqxNAgSZI6MTRIkqRODA2SJKkTQ4MkSerE0CBJkjoxNEiSpE4MDZIkqRNDgyRJ6sTQIEmSOjE0SJKkTgwNkiSpE0ODJEnqxNAgSZI6MTRIkqRODA2SJKkTQ4MkSerE0CBJkjoxNEiSpE4MDZIkqZP/B/x0b9RDfw+wAAAAAElFTkSuQmCC"></div></div></div></div></td>
    </tr>
    <tr id="table_high_2_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0504010L0AAAAAA&amp;denomIds=5.4.1&amp;selectedTab=summary" target="_blank">Mefloquine 250mg tablets : 52</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0504010L0BBAAAA&amp;denomIds=5.4.1&amp;selectedTab=summary" target="_blank">Lariam 250mg tablets : 2</a></li></ul></td></tr><tr class="row_4">
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0504010U0&amp;denomIds=5.4.1&amp;selectedTab=summary">Proguanil hydrochloride with atovaquone</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_high_3_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>52</td>
      <td>Antimalarials</td>
      <td>30761</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>5.42</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_HQmIBrBZSomCEkLhTpSgoNCQAqyAuGCE"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_HQmIBrBZSomCEkLhTpSgoNCQAqyAuGCE" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
    <tr id="table_high_3_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0504010U0AAAAAA&amp;denomIds=5.4.1&amp;selectedTab=summary" target="_blank">Proguanil 100mg / Atovaquone 250mg tablets : 9</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0504010U0AAABAB&amp;denomIds=5.4.1&amp;selectedTab=summary" target="_blank">Proguanil 25mg / Atovaquone 62.5mg tablets : 2</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0504010U0BBAAAA&amp;denomIds=5.4.1&amp;selectedTab=summary" target="_blank">Malarone 250mg/100mg tablets : 33</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0504010U0BBABAB&amp;denomIds=5.4.1&amp;selectedTab=summary" target="_blank">Malarone Paediatric 62.5mg/25mg tablets : 8</a></li></ul></td></tr><tr class="row_5">
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0801030T0&amp;denomIds=8.1.3&amp;selectedTab=summary">Tioguanine</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_high_4_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>8</td>
      <td>Antimetabolites</td>
      <td>868</td>
      <td>0.01</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>5.31</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_EGOADjEprYjbShIECuMFRbAUFeIl2kKF"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_EGOADjEprYjbShIECuMFRbAUFeIl2kKF" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAg0AAACWCAYAAABdJrs9AAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAAXEQAAFxEByibzPwAAADh0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uMy4xLjMsIGh0dHA6Ly9tYXRwbG90bGliLm9yZy+AADFEAAAPDElEQVR4nO3de5AlZX2H8edlZxcWEIkbQ1YX6JIAIlTQoCGoEMWogbaECCGJAS0lFRJJEGOADjEprYjbShIECuMFRbAUFeIl2kKFJBJAJQRlXe64UC1yVQEBV2Czs50/ugeGYWanZ8/pec/l+VR19enL6f31e86c/u57+nSHqqqQJEmaz1axC5AkScPB0CBJkloxNEiSpFYMDZIkqRVDgyRJasXQIEmSWjE0SJKkVgwNkiSpFUODJElqxdAgSZJaMTRIkqRWDA2SJKkVQ4MkSWrF0CBJkloxNEiSpFYMDZIkqRVDgyRJasXQIEmSWjE0SJKkVgwNkiSpFUODJElqxdAgSZJaMTRI0jgJYTtCqJphu9jlaLgYGiRJUisTsQuYS5IVxwPXAGvLPH0idj2SJI27UFVV7BpmlWTFVGEbgOuAy4HVZZ4+HK0oSRp29VcSP2+mtqeq1scsR8NlkL+eeB9wCfAosD9wCrAmyYoDolYlSdKYGtiehilJVgRgN2A1cCQwCbyXutdhMmJpkjR87GlQDwY+NExpwsPbgbOAbYErgaPLPL0zamGSNEwMDerB0ISGKUlW7AlcCLwEeAB4RZmnt8atSpKGhKFBPRjkcxpm1QSEA4CPASuAbyRZ8dy4VUmSNPqGLjQAND/BfAdwMfAC4KtJViyPW5UkSaNtKEMDQJmnm4C3AFdT9zxckGTF0O6PJEmDbqgPsmWePgYcBtxB/cuK1XErkiRpdA11aAAo8/THwKHAQ8DJSVYcF7kkSZJG0tCHBnjy5MjDqa8eeXaSFftGLkmSpJEzEqEBoMzTK6ivGrkUOD/JimWRS5IkaaSMTGhonAVcAewLvCdyLZIkjZShu7jTfJKseAGwFtgG2L/M0+9GLkmSBocXd1IPRq2ngTJP7wBOApZQf02xdeSSJEkaCSMXGhofBf4D2Jv6bpmSJKlHI/f1xJQkK3YBrge2p74/xdWRS5Kk+Px6Qj0Y1Z4Gmrtfvot6H8/z1xSSJPVmZEND4zzqryleCJwQuRZJkobayH49MSXJir2of03xOLBnmaf3RC5JkuLx6wn1YNR7Gijz9GbgDOpzG/4xcjmSJA2tkQ8NjX8A7gH+KMmKV0WuRZKkoTQWoaHM00eBdzeTZydZsTRmPZIkDaOxCA2NLwD/DewDHB+5FkmShs7Inwg5XZIV+wBrgPXUJ0XeF7kkSVpcngipHoxTTwNlnt5AfVOrHYAPRi5HkqShMlahofFe4H7gLUlW/GbkWiRJGhpjFxrKPH0E+Ntm8swkK0LMeiRJGhZjFxoanwa+B/wW8Oa4pUiSNBzGMjSUeToJnNhMfjDJiu1i1iNJ0jAYy9AAUObpldQ/w3w+cErkciRJGnhjGxoaJ1Pfk+KkJCt2jV2MJEmDbKxDQ3P77A8B2zRjSZI0h7EODY0PAXcDRyVZcWDsYiRJGlRjHxrKPF1P/TUF1PelmIhZjyRJg2rsQ0PjQuAqYF/guMi1SJI0kMbq3hObk2TFvtTXbngE2KPM059ELkmS+s97T6gH9jQ0yjz9PnAOsCOwOnI5kiQNHEPD0/098BPg2CQr9o9djCRJg8TQME2Zpz/jqQs9nZNkxZKY9UiSNEgMDc90PvA/wH7AsZFrkSRpYHgi5CySrNgP+F/gIeqTIh+IXJIk9YcnQqoH9jTMoszT7wIfB54DnB65HEmSBoKhYW6nAvcDb0uy4nWxi5EkKTZDwxzKPH0Q+PNm8hNJVjwrZj2SJMVmaNiMMk+/DFwE7ILXbpAkjTlDw/z+EngQON4bWkmSxpmhYR5lnt4PvLOZ/GSSFctj1iNJUiyGhnY+CxTA7sD7ItciSVIUXqehpSQrVgE3AtsDryzz9DuRS5KkhfM6DeqBPQ0tlXl6F/BX1G32hSQrVkQuSZKkRWVoWJhPAZ8DdgYuSLLC9pMkjQ0PegtQ5mkFHAfcAhwKnBy3IkmSFo/nNGyBJCv2Aa4BlgEHl3l6ReSSJKkdz2lQD+xp2AJlnt4AvANYAnw+yYpfiVySJEmdMzRsoTJPPw2cB6wEPptkxZK4FUmS1C1DQ2/+ArgB+B3gI0lWhMj1SJLUGUNDD8o8/QVwGHAf8KfA++NWJElSdwwNPSrz9A7g9cDDwKlJVpwYuSRJkjphaOiDMk/XAm8AHgfOSLLimMglSZLUd4aGPinz9CrgSGASOC/JijRySZIk9ZWhoY/KPC2At1H/FPNfk6z4/cglSZLUN17cqQNJVvwZcA51KDsVyJurSUpSXF7cST2wp6EDZZ5+FDgcWA98ADg3yYplcauSJKk3hoaOlHn6NeBA4B7g7cAlSVb8UtyqJEnacoaGDpV5eh2wP7AGOBi4JsmKg+JWJUnSlvGchkWQZMX2wGeov7IA+BhwSpmnD8erStJY8pwG9cCehkVQ5unPgTcBRwMPUN9e+8YkK94YtTBJkhbAnoZFlmTFc4EPA29uZv0bcFqZp9fEq0rS2LCnQT0wNETSXPzpX4Cdm1nfBHLgMn+eKakzhgb1wNAQUZIVWwPHACcDuzezrwM+AnylzNOfxqpN0ogyNKgHhoYBkGTFEuD3gAzYr5k9CVwOXAx8uczT++NUJ2mkGBrUA0PDAEmyIlBf2+EPgCOAnZpFFXA98B3g2814nV9jSFowQ4N6YGgYUE3vw8upb4J1OLDLjFUeAG4CbgNubcbrgLuBhw0UkmZlaFAPDA1DIsmKVcAB04bfAOa6NPVjwL3NcD/wM+AR4OHNjNcDTwAbmvETZZ5OdrQ7I6PpHVoCLG05LFvAunM9dwII1D+ZDjOGmfNmTkP91demzQxzLf+/WYYNfZy3oczTTQtp/3E07T23hPq9MDHt8Vzjiann73Pfum2+fv6JVwMcdsw/v+z7z9vjF82iasYwNW/m+2KyzWP/49Je85puxYzXrczTh6IWNgtDw5BKsmIC2BXYoxn2BHYDngesBFb04Z+ZZFqImDbMnNfqQ6TlvE08dXALfXg824fn5ob51pvtwK/+qYCNPBUkNs4x3tyyqfH0A+AmnnlQXMhyqN8bW80zbruszUF+rmU9XV9n+YbHufmMIwHY610X89iybXrZ3OZULDBozPO439uCuV+bNq/rzMdbEuSmz3uGMk/DbPNjmph/FQ2iMk83Arc3wyUzlze/zPhV6vMidgCePc94O2DrZlg27fHUsC1z92yMi0meOmA9Rt1LM9v/vucbZvtf90Keu5HZD3TzTU8d/LbazLBkM/MnmL2nZOa8NutsrtdlYtp4OfCsZnrgPkA7MnVQ2zht/MSM6anxbPPmWqcCwsSmyQngEICJTZP/3iyb2WMFT++tmv4+mO/AOd96S6k/U6bPH/ULDU6F4emvyWPM//oNnIHsaQgh3AhQVdXesWsZdLZVe7ZVe7ZVe7ZVe7ZVO4PcTqOe7iRJUp8YGiRJUiuGBkmS1IqhQZIktWJokCRJrRgaJElSKwP5k0tJkjR47GmQJEmtGBokSVIrhgZJktSKoUGSJLViaJAkSa0YGiRJUiuLEhpCCK8KIdwYQlgXQjg3hPCMe4eHEI4KIdwWQrg9hHDatPk7hBC+FkL4QQjh2hDCXvM9Z5h10VYhhBeHEL7VbPeGEMIJi7lPXenqfTVtnSKEsK7r/ehah39/O4UQvhpCuCWEcGsI4Q2LtU9d6bCt/rrZ7toQwqUhhJ0Wa5+60mNbHRJCWBNC2BhCOHqh2x02XbRVCGHnEMJ/hhBubra9elF2pqqqTgfqYLIOeFEz/UXgrTPWeTZwJ7ASmAC+Dfx2s+z9wAeax4cC35zvOcM6dNhWewB7No93AH4AvDj2/g5iW0177h8DnwHWxd7XQW0n4FLgqObxBLAi9v4OYlsBuwO3A8ub6Rw4Pfb+Rm6rXwP2AS4Ajl7Idodt6LCtVgIvbR4vA64EDut6fxajp+FlwD1VVd3UTH8SOGLGOr8LXF5V1b1VVW0Ezp+2zhHAuQBVVX0D2COEsGKe5wyrTtqqqqrbqqq6tZn/CHAzsHO3u9K5rt5XhBB+GTgeGIXeq07aKYSwJ7BTVVVfbJZtrKrqgY73pWtdvacCsBRYHkII1MH93k73pHs9tVVVVeuqqroB2LQF2x02nbRVs+61zeMNwHXALt3tRm0xQsMq4EfTpu/kmQesza0zc9ldzbw22x02XbXVk0IIuwEvBb7Vh3pj6rKtPgy8B3i8X8VG1FU7vRD4cQjhwhDCdSGEC0IIz+lr5Yuvk7aqquo24Oxm2b3A3sCZ/Ss7il7bqpftDpuu2upJzd/e4cBlW1hja4sRGkKf1unHcwZdV21VPzGEHYGvAO+squrBLd3OgOikrUIIhwCTVVX918JLGkhdvacmgIOA06qqeglQAqdvwXYGSVfvqRXAm6i7mZ8P3AGctNDtDBg/19vr+nN9GXAxcGZVVbds6XbaWozQ8COenph2oU7gbde5a8ayVcDdLbc7bLpqK0II2wIF8Imqqi7qY82xdNVWBwGvCSGUwFXAriGEtf0re9F1+fd3U9NtCvB5YL8+1RxLV211MHBH0508CVwEvLyPdcfQa1v1st1h01Vb0ZxQ+TlgTVVV/9Rjna0sRmi4FlgVQnhRM30s8KUZ61wKvDqEsDKEMAG8ddo6XwL+BCCEcCj1iWk/nec5w6qTtgohLG2WXVZV1Vld78Qi6aStqqr6m6qqVlVVlQCvBH5YVdWvd7wvXerq7+9aYFkIYeqD7rXAjd3txqLoqq1+COwfQtihWe+1wE0Mt17bqpftDpuu2grg48CjwLv7Vey8Funs0YOp/0huBz5F3bX5RuDcaev8IfVZ/bcDq2ecVfr1Ztn3gL3ne84wD120FfUvASaBNdOGI2Pv6yC21YztJwz5rye6bCfgwGbeWuASYGXsfR3gtvo74BbgeuqDwY6x9zVyW72G+n/S64EHm8dbz7Xd2Ps6iG0FvAKomvfU1Of6CV3vi7fGliRJrXhFSEmS1IqhQZIktWJokCRJrRgaJElSK4YGSZLUiqFBkiS1YmiQJEmtGBokSVIrhgZJktSKoUGSJLViaJAkSa0YGiRJUiuGBkmS1IqhQZIktWJokCRJrRgaJElSK4YGSZLUiqFBkiS1YmiQJEmtGBokSVIrhgZJktSKoUGSJLViaJAkSa0YGiRJUiv/D2fZ8CJDgf5GAAAAAElFTkSuQmCC"></div></div></div></div></td>
    </tr>
    <tr id="table_high_4_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0801030T0AAAAAA&amp;denomIds=8.1.3&amp;selectedTab=summary" target="_blank">Tioguanine 40mg tablets : 8</a></li></ul></td></tr><tr class="row_6">
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0704010C0&amp;denomIds=7.4.1&amp;selectedTab=summary">Bethanechol chloride</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_high_5_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>76</td>
      <td>Drugs for urinary retention</td>
      <td>95213</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>5.18</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_0Uhpq6TKUsFWSyWJRQFiBCkuSoAqoJWL"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_0Uhpq6TKUsFWSyWJRQFiBCkuSoAqoJWL" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAg0AAACWCAYAAABdJrs9AAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAAXEQAAFxEByibzPwAAADh0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uMy4xLjMsIGh0dHA6Ly9tYXRwbG90bGliLm9yZy+AADFEAAAQCElEQVR4nO3de7AkZXnH8e+7uywsu4ALcjOAjVyErBIlmCBqKZcykFYSZIuLLCUY0CQg0Uhpq6TKUsFWSyWJRQFiBCkuSoAqoJWLkRANaEIIKmAQMF2wIIar6O6yNzp/dB+ZPZyz22fOzLxn5nw/VW/NTHfPzPOc7tn57Tu3UFUVkiRJmzIndgGSJGk4GBokSVIrhgZJktSKoUGSJLViaJAkSa0YGiRJUiuGBkmS1IqhQZIktWJokCRJrRgaJElSK4YGSZLUiqFBkiS1YmiQJEmtGBokSVIrhgZJktSKoUGSJLViaJAkSa0YGiRJUiuGBkmS1IqhQZIktWJokCRJrRgaJElSK4YGSZI2JYSFhFA1Y2HscmIxNEiSpFbmxS6gjSQrlgKHAPOBVcDK5vTXwI1lnv4sYnmSJM0Koaqq2DVsUpIVmyryLuBy4IoyTx8bQEmSpNmkfknit82lRVTVipjlxDIsoeES4DvAU8ACYMvmdDfgWGDfZtMKuAX42zJP741QqiRpFBkagCEJDRuTZEUAXgecABwPvAJYC5wNfLbM0zURy5MkjQJDAzACoaFTkhXzgL8BPk09E3EvcEqZpz+MWpgkabgZGoARCw1jkqzYA7iQ+s2TFfBFICvzdH3UwiRJw8nQAIzoRy7LPH0IOAz4C+A54Ezg6iQrtoxamCRJQ2wkZxo6JVmxO3AjsDfwQ+CdZZ4+GbcqSdJQcaYBGNGZhk5lnv4v8CbqwHAg8O9NkJAkSVMw8qEBoJlZOBS4jnrG4Y4kK/aPW5UkScNlVoQGgDJPVwJHA+cDOwLfTbLiNXGrkiRpeMya0ABQ5uk64K+BLwCLgZt9qUKSpHZmVWgAKPO0Aj4KXATsTD3jsHPcqiRJmvlmXWiA3wWHvwSuAl4F3JRkxeK4VUmSNLPNytAA0HzR04nAzcBrgSLJiln7G+mSJG3KrA0NAGWergbeBdwBvBG4IsmKuXGrkiRpZprVoQGgzNMVQArcD7wTOCduRZIkzUyzPjQAlHn6DHVgeAb4SJIVJ8WtSJKkmcfQ0Cjz9AFgKbAOuDDJijdHLkmSpBnF0NChzNPvAacDmwHXJlmRxK1IkqSZw9AwTpmnFwD/ALwcuCHJiq0jlyRJ0oxgaJjYh4GbgCXAxUlW+HeSJM16PhlOoPm66eOAB4GjgCxuRZIkxWdomESZp89SB4YVwGeSrDgickmSJEVlaNiIMk/vAU4GAnB5khV7RC5JkqRoDA2bUObpVcDngZdRf6LCr5qWJM1KhoZ2Pg7cQv0bFV9LsiJErkeSpIEzNLTQ/LjV8UAJHEv96QpJkmYVQ0NLZZ4+Rf3GyFXA55KsOCxySZIkDZShYQrKPL0bOJX673al3xgpSZpNDA1TVObpZcC5wHbANUlWLIhckiRJA2Fo6M5HgNuA1wMX+MZISdJsYGjoQpmna4FjgOXAicAH4lYkSVL/GRq6VObp/wHvAlYDX0qy4tDIJUmS1FeGhmko8/Q/qd8YORe4KsmKPSOXJElS3xgapqnM00uBLwCLgeuTrNgmckmSJPWFoaE3PgYUwD7AFUlWzI1cjyRJPWdo6IHmGyPfDdwHHAHkcSuSJKn3DA09Uubpc8CRwNPAmUlWnBy5JEmSesrQ0ENlnj4ELAXWARcmWfH2yCVJktQzhoYeK/P0VuAUYB5wdZIV+0cuSZKknjA09EGZp5cAZwGLgMLfqJAkjQJDQ/+cA1wA7ATcmGTFdpHrkSRpWgwNfVLmaQWcDlwPvBq4zh+3kiQNM0NDH5V5ug44DvgRcBD1r2JuHrcqSZK6Y2joszJPVwLvAO4BDqd+c6TBQZI0dAwNA1Dm6ZPAYcDPgBT4VpIV8+NWJUnS1BgaBqTM018BhwD3U38J1JVJVmwWtypJktozNAxQmaePUweHB4GjgMsNDpKkYWFoGLAyTx8DDgZ+Qf3tkdclWbEoblWSJG2aoSGCMk+XA2+j/oGrw4Fbk6zYIWpRkiRtgqEhkjJPHwHeDHwfOAC4PcmKPeJWJUnS5AwNEZV5+gzwduBqYA/gjiQrDohblSRJEzM0RFbm6fPAscBXgO2B25KsWBa3KkmSXipUVRW7BgFJVgTgw8DnqMPc+cCHmlAhSYophIXAb5tLi6iqFTHLicXQMMMkWXEwcCWwA/BfwNIyT8uoRUnSbGdoAHx5YsYp8/RW4PXAD4A/BO5KsuLIuFVJkuRMw4zVfOnTZ6lfsgC4HPhgmadPxKtKkmYpZxoAQ8OMl2TFO6jf3/B7wJPAGcCVzU9vS5IGwdAA+PLEjFfm6Q3AEuAC4OXUMw7XJVnxyqiFSZJmHWcahkiSFW8FLgL2BNZQf0zznDJPn4pamCSNOmcaAEPD0EmyYgHwUeBMYCHwHPXHNP++zNNZeRBLUt8ZGgBDw9BKsmJH4O+A9wPzgMeBc4Gvlnn6dMzaJGnkGBoAQ8PQS7JiT+DTwHHNopXAJdQzD/dHK0ySRomhATA0jIwkK/ah/mTFScCCZvGN1AHiujJPV0YqTZKGn6EBMDSMnCQrtgVOBT5A/TFNqA/0a4DLgO+VebouUnmSNJwMDYChYWQ1Xw71J8AJwJ/x4uzDU8BNwHeAm/yyKElqwdAAGBpmhSQrtgL+HHg3cCiwWbOqAu4E/gW4HbijzNMnoxQpSTOZoQEwNMw6TYA4BDiiGbuN2+R+6gBxF/Bj4Kdlnj470CIlaaYxNACGhlmt+TnufYA3A28CDgL2mmDTh4GfAD8HHgQeaMYjZZ6+MJhqJSkiQwNgaNA4SVZsDxwI/EEz9qMOEmGCzdcCjwKPNGM58Bj1b2SMjSeAJ/30hqShZmgADA1qIcmKhcC+1F9fvVfH2B3YseXNrGLDMPEc9QPwNx2nvxm3bAXwfDNWd5wfu7zGH+6SNBCGBsDQoGlKsmJz6o927gLsCuxE/cNaY2P7jvPbMvGMxXRMFCpWd4zxlycb093ueV+qkUaYoQEwNGiAkqyYByymDhBbAYs2cboQ2LwZWzRjY+c3H1w3E3qe+hs5pzpWTGHbtc6uSBEYGgBDg0ZIkhVzgPlsGCImGhtb3+26Bc3Ykjrs9HpGZcx6XgwQqzpOJxqTrZto+fPUv5w6NlaPu7zWmZTh1zxG5gFzm9POMdGyQP3R7E2NF1pusx5Y15x2jnUzPgwbGgBDg9RzzadS5lMHiM6xcIJl3Y6FzX0M0jo2DBJrqN8MO/4JoHO8MMX1kz0JTfSk1Mtl3VxvzkbG3Cmum8oT+XS27VeY7YWKjhDBBMGiy2U9ua1tVz47565/XHYWwAGnX/qJJxcuXjWN2183bqxtuWwddcCKFuANDdKQSrJiLvXsx9gMx4JxY6JlEy3fknq2ZP4Ux+bM7Ceh2egFXnxymejJabLlky2rqPdxmzGnxfq5vBhi5m7k8mTL5vbuTzU1C9Y8z8++vBSAfT/0z6yav0WsUmDD/TxhwCjzdM9+3PG8ftyopP4r83Q99fshok2TNsFlsjFnI+smW7+xJ6B+L5vq9cZmSV6YZLRdVzG9J/ff/Q921F9Cambxxh833QaQNst+d3nr1SsWAOcBLFqz8sxV87dYP43bHzvdjIlnh6a6fIuO830NVjN+piGEcC9AVVVLYtfSK6PW06j1A6PX06j1A6PX06j1A6PX06j10405sQuQJEnDwdAgSZJaMTRIkqRWDA2SJKkVQ4MkSWrF0CBJklqZ8R+5lCRJM4MzDZIkqRVDgyRJasXQIEmSWjE0SJKkVgwNkiSpFUODJElqZSChIYTwthDCvSGEB0MIF4UQXvLTnSGEY0IIPw8hPBRCOLtj+dYhhOtDCA+EEO4MIew7nesMaT9HhBDuDiGsCyEs62UvEXv6fAjhf0IIPw4h3BJCeOWQ93NaCOEnzX66M4Tw1l72E6OnjvUHhhDW9/rYi7CPPhlC+GWzj+4OIXyil/3E6KlZd3II4b4Qwj0hhJuHvacQwvkd++i+UP+7t+0Q97N7COHWEMJ/N/d7Sq96iaKqqr4O6mDyIPD7zeVvAe8Zt802wMPAztS/B3478NZm3WeAc5rzfwrc2u11hrifPYHXAN8Alo3IPjoc2Kw5/1fAtUPez9Ydt/06oBz2fdSsnw/8G1D08tiLtI8+CZzV68dP5J7eCNwxdvwBOw17T+Nuexlw8zD3A1wGvK85vz3wLLBVv47Dfo9BzDS8AXisqqr7mstfA44et83hwL9WVfXLqqrWAZd0bHM0cBFAVVXfBvYOIWzX5XWGsp+qqh6squoe4IUe9TATerqxqqq1zfV/BOw25P0813HbC4Fef2tajMcRwMeBi4EnRqSfforR0xlAPnb8VVX1+Aj01OkE4NIR6Geb5nQR8GtgTQ97GqhBhIZdgEc6Lj8M7DqFbcavW94s6+Y6vRCjn36L3dP7gW9PuerJRemnmSb+OXA9cOI06p/IwHsKISwBDgK+Ps3aJxLrmHtfqF9GujaEsFf35U8oRk/7APuHEG4PIfxHCGHptDp4qWj/NoQQdqCeSbmmy9onEqOfjwEnhRCWA/cAp1VVtXoaPUQ1iNAQerRNL67TC6PWT9v77ktPIYRTgdcD53Rx+13fb8ttpnSdqqq+XlXV3tRTqp/q4va7vu8pbNPqOiGEOcB5wBlVM6/aYzH20fnAHlVV7QdcSR3ueilGT/OAVwJvAY4CvhhCeFUX99HNfU9lm26uczxwQ1VVK7q4/encb6/7OQ74ZlVVuwB/DJwXQljUxX3MCIMIDY+wYZLbjTqdtd1m+bh1uwCPdnmdXojRT79F6SmEcDTwQSCtqmrVNOofL+o+aqYtXxtCWNxN8ZMYdE9bAUuAG0MIJbAU+HII4b3T6qJdrW22mfI+qqrq8bGXxKqq+ibwsh6+bLmpetts081x9whwdVVV66uqepT6pb79ptHDeDEfS8vo7UsTtLzfXvfzHuAKgOZl5seBvbvuILZ+v2kCmAv8gg3feHLyuG22of6jd76J5OBm3dls+MaT27q9zrD203G7F9OfN0LG2EeHAQ8Au41IP6/uuO23AMuHvad+HnuR9tErOm774Ga7MOQ9vRc4t2O7hzqPxWHsaezxBDwGzB32xxH1S6+nNed3BX4FLO5lX4Mcg7kTOAS4rzmg/6n5ox4JXNSxzXHUTyIPAZ8dtwNvaNbdBSyZznWGtJ9DqVPrCuDp5vzmQ97TA9QJ/e5mfHfI+/kKcG/Tyw+APxr2x9G4+76YHgfWCPvoG8BPm330feANw76Pmtv/anPs3QOcOuw9Nes+BXyp171E2kf7NMfbT5rj75h+9DWo4U9jS5KkVvxGSEmS1IqhQZIktWJokCRJrRgaJElSK4YGSZLUiqFBkiS1YmiQJEmtGBokSVIrhgZJktSKoUGSJLViaJAkSa0YGiRJUiuGBkmS1IqhQZIktWJokCRJrRgaJElSK4YGSZLUiqFBkiS1YmiQJEmtGBokSVIrhgZJktSKoUGSJLViaJAkSa0YGiRJUiv/DyjVqrOn5w9qAAAAAElFTkSuQmCC"></div></div></div></div></td>
    </tr>
    <tr id="table_high_5_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0704010C0AAAAAA&amp;denomIds=7.4.1&amp;selectedTab=summary" target="_blank">Bethanechol chloride 10mg tablets : 7</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0704010C0AAABAB&amp;denomIds=7.4.1&amp;selectedTab=summary" target="_blank">Bethanechol chloride 25mg tablets : 33</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0704010C0BBAAAA&amp;denomIds=7.4.1&amp;selectedTab=summary" target="_blank">Myotonine 10mg tablets : 36</a></li></ul></td></tr><tr class="row_7">
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0501021B0&amp;denomIds=5.1.2&amp;selectedTab=summary">Cefadroxil</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_high_6_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>67</td>
      <td>Cephalosporins</td>
      <td>7764</td>
      <td>0.01</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>5.16</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_U4ixBZ3EFkGaiFxsAFturUJ1Ci1WC4pa"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_U4ixBZ3EFkGaiFxsAFturUJ1Ci1WC4pa" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
    <tr id="table_high_6_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0501021B0AAAAAA&amp;denomIds=5.1.2&amp;selectedTab=summary" target="_blank">Cefadroxil 500mg capsules : 67</a></li></ul></td></tr><tr class="row_8">
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=1302010F0&amp;denomIds=13.2.1&amp;selectedTab=summary">Emulsifying wax</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_high_7_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>4004</td>
      <td>Emollients</td>
      <td>67452</td>
      <td>0.06</td>
      <td>0.01</td>
      <td>0.01</td>
      <td>4.87</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_HURjjGKrEC8QwVIBCVGhopjSxhVMSSGi"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_HURjjGKrEC8QwVIBCVGhopjSxhVMSSGi" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
    <tr id="table_high_7_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=1302010F0AAADAD&amp;denomIds=13.2.1&amp;selectedTab=summary" target="_blank">Emulsifying ointment : 4004</a></li></ul></td></tr><tr class="low_number row_9">
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0504080P0&amp;denomIds=5.4.8&amp;selectedTab=summary">Pentamidine isetionate</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_high_8_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>1</td>
      <td>Drugs for pneumocystis pneumonia</td>
      <td>1</td>
      <td>1.00</td>
      <td>0.05</td>
      <td>0.21</td>
      <td>4.53</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_STUVk1QKLdtoVGJMibCFiRopoChRGhEI"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_STUVk1QKLdtoVGJMibCFiRopoChRGhEI" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
    <tr id="table_high_8_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0504080P0AAAAAA&amp;denomIds=5.4.8&amp;selectedTab=summary" target="_blank">Pentamidine 300mg powder for solution for injection vials : 1</a></li></ul></td></tr><tr class="row_10">
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0601023AD&amp;denomIds=6.1.2&amp;selectedTab=summary">Metformin hydrochloride/sitagliptin</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_high_9_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>7055</td>
      <td>Other antidiabetic drugs</td>
      <td>206449</td>
      <td>0.03</td>
      <td>0.01</td>
      <td>0.01</td>
      <td>4.13</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_SpkKlbA0UGqMMbF0EPcllIhOWjGCWm5x"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_SpkKlbA0UGqMMbF0EPcllIhOWjGCWm5x" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
  <tr id="table_high_9_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0601023ADAAAAAA&amp;denomIds=6.1.2&amp;selectedTab=summary" target="_blank">Metformin 1g / Sitagliptin 50mg tablets : 5130</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0601023ADBBAAAA&amp;denomIds=6.1.2&amp;selectedTab=summary" target="_blank">Janumet 50mg/1000mg tablets : 1925</a></li></ul></td></tr></tbody></table>
        </div>
      </div>
    </section>

    <section aria-labelledby="lowerHeading">
      <div class="container">
        <h2 class="pb-3" id="lowerHeading">Prescribing where NHS South East London CCG is lower than most</h2>
        <button id="lowerHeading-lowShowHide" class="btn btn-outline-danger-outline mb-3" type="button">Hide low numbers</button>
      </div>
      <div class="container mb-4">
        <div class="table-responsive">
          <table border="1" class="dataframe table table table-sm table-bordered" id="table_low">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="Standard Deviation">std</abbr></th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr class="low_number row_1">
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0504080A0&amp;denomIds=5.4.8&amp;selectedTab=summary">Atovaquone</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_low_0_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>0</td>
      <td>Drugs for pneumocystis pneumonia</td>
      <td>1</td>
      <td>0.00</td>
      <td>0.95</td>
      <td>0.21</td>
      <td>-4.53</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_UlZIGTqgiYC4VLAwQ1EQwAW1CSkFhICo"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_UlZIGTqgiYC4VLAwQ1EQwAW1CSkFhICo" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
    <tr id="table_low_0_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"></ul></td></tr><tr class="row_2">
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=1311060Q0&amp;denomIds=13.11.6&amp;selectedTab=summary">Potassium permanganate</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_low_1_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>128</td>
      <td>Oxidisers and dyes</td>
      <td>191</td>
      <td>0.67</td>
      <td>0.94</td>
      <td>0.10</td>
      <td>-2.70</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_QbFjqINO1wUESjSgnIRFenBwkZwYqi"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_QbFjqINO1wUESjSgnIRFenBwkZwYqi" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
    <tr id="table_low_1_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=1311060Q0AAACAC&amp;denomIds=13.11.6&amp;selectedTab=summary" target="_blank">Potassium permanganate 400mg tablets for cutaneous solution : 115</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=1311060Q0BBAAAC&amp;denomIds=13.11.6&amp;selectedTab=summary" target="_blank">Permitabs 400mg tablets for cutaneous solution : 13</a></li></ul></td></tr><tr class="row_3">
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=1312000C0&amp;denomIds=13.12&amp;selectedTab=summary">Aluminium chloride</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_low_2_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>709</td>
      <td>Antiperspirants</td>
      <td>745</td>
      <td>0.95</td>
      <td>0.99</td>
      <td>0.02</td>
      <td>-2.65</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_E8G4QLmDSgyKghEwCBqNFBrwBGOMigIC"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_E8G4QLmDSgyKghEwCBqNFBrwBGOMigIC" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAg0AAACWCAYAAABdJrs9AAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAAXEQAAFxEByibzPwAAADh0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uMy4xLjMsIGh0dHA6Ly9tYXRwbG90bGliLm9yZy+AADFEAAASP0lEQVR4nO3debQkZX2H8eeFAWaYYZFVQLCiKAgKbrjFhXBEhRLjQUKiaAQ0IBo9CAoVE8G4QLmDSgyKghEwCBqNFBrwBGOMigICOoAsUoowsors21D5o97L9L3MvbdmbndXV9/nc06d6uqurv693VPT3/t21VuhqiokSZJms0bbBUiSpG4wNEiSpEYMDZIkqRFDgyRJasTQIEmSGjE0SJKkRgwNkiSpEUODJElqxNAgSZIaMTRIkqRGDA2SJKkRQ4MkSWrE0CBJkhoxNEiSpEYMDZIkqRFDgyRJasTQIEmSGjE0SJKkRgwNkiSpEUODJElqxNAgSZIaMTRIkqRGDA2SJgthMSFUcVrcdjmSRoehQZIkNbKg7QIkSYOVZMWGwEHAE4F1gV8AXy7z9O5WC1PnhKqq2q5B0iipf5KY+DJZQlXd02Y5Wn1JVqwBvBM4CthoysO3Ax8Cji/z1C8CNeLPE5I0hmJg+CJwHLAhcBLwGmAP4N+ADYBPA8cmWRHaqlPd4s8TkjRmYmA4ETgQuBHYo8zTy3pW+V6SFZ8FzgWOpP4ueM/QC1Xn2NMgSePnCOCtwDJg1ymBAYAyTy8EdgNuBQ5PsmKf4ZaoLvKYBkmTeUxDpyVZ8Rzgp8DDwHPLPF06y/q7U/c43AY8o8zTZYOvUl1lT4MkjYkkK9YFTqP+ueHw2QIDQJmn5wGfAzYGTvL4Bs3E0CBJ4+MDwHbAOcDnV+F5RwJXAXsCe/W/LI0Lf56QNJk/T3RSkhVPBq4AHgSeWubpjav4/BQ4G1gK7Fzm6fL+V6mus6dBksbDx4C1gGNXNTBE5wD/C+wIvKmfhWl8GBokqeOSrNgV2Bv4HfCp1dlGHODpyLj4wSQrFvanOo0TQ4MkdVg8cPGYuJiVeXrf6m6rzNOfAN8Gtgbe2IfyNGYMDZLUbS8HXgj8CjijD9s7Ns4Pj4NESY/yH4QkdVTsZTg6Ln6wzNNH5rrNMk8vAH4EbE99NoX0KEODJHXXbsCfU5/x8I0+bveTcX54H7epMWBokKTu+sc4/3A/ehl6fAe4Gtg1jjApAYYGSeqk+GX+F8A1wJn93HYco+H4uHhIP7etbjM0SFI3TVyV8lMDGojpVOBe4PVJVmwwgO2rgwwNktQxSVYkwF9RX6HyK4N4jTJP/wR8DVgX2G8Qr6HuMTRIUvccCqwJnFDm6b0DfJ0T4/xtXshKYGiQpE6JPxW8BXgA+JcBv9yFwMXAM4AXDPi11AGGBknqlgOAJcCpZZ7ePMgXikNLfyEuHjjI11I3GBokqSOSrFgTeGdcPH6mdfvoDOpejX2TrFg0pNfUiDI0SFJ3pMCTgPPLPP3lMF6wzNM7gG8B6wOvHcZranQZGiSpOw6N82H1Mkw4Jc7fPOTX1YgxNEhSByRZsRP1YE7XAWcP+eXPA5YBuydZsdWQX1sjxNAgSd3wrjj/zIAGc5pWfL1Tqb8zvGT2PGZokKQRl2TFJtQDLN0NnNxSGRODSL3ZMRvmL0ODJI2+g4CFwMlxpMahK/N0KfW4DU8DnttGDWqfoUGSRliSFWsDbwcq4LMtl/Nob0OrVag1hgZJGm37AlsBRZmnV7dcy9eAh6gvYrVOy7WoBYYGSRpR8diBiatZfqLNWgDKPL2N+syNjajHjNA8Y2iQpNG1G7AzcBHww5ZrmXBKnO/fYg1qiaFBkkbX4XH+yXgdiFHwXeAWYM8kKzZvuxgNl6FBkkZQkhU7AnsAvwPOarmcR5V5+hBwGvWlud/QcjkaMkODJI2mw+L8+PhFPUpOiXPPophnDA2SNGKSrHg89ciLdwIntVzOY5R5eilwKbBzkhXPbLseDY+hQZJGz98DawNfKPP0zraLmcYpcb5/izVoyAwNkjRCkqxYDBwCPAx8puVyZnI6dY37xQGoNA8YGiRptBxMPQ7CGWWeXt92MdMp8/Rm4BxgE+oDNjUPGBokaUQkWbEIOIJ6yOhjWi6niVPifP8Wa9AQGRokaXQcBGwOnFnm6eVtF9NAAdwGvDrJik3bLkaDZ2iQpBGQZMVC4Mi4+KE2a2mqzNMHqY9tWAC8vuVyNASGBkkaDYcAWwDfKPP0V20Xswomrnx5QLxWhsaYoUGSWpZkxYbAPwGPAEe1XM6quph6zIZnAru0XIsGzNAgSe07gvqMiZM7cizDo+I1MU6Miwe3WYsGz9AgSS1KsmIr4FDgfuDolstZXacB9wB/k2TFBm0Xo8ExNEhSuz4KLAKOK/P0hraLWR1x1MqvAetSD3+tMWVokKSWJFnxMmA/4Ea6MS7DTCZ+onibB0SOL0ODJLUgyYq1gBPi4uFlnt7VZj19cBFwIfB0YNd2S9GgGBokqR2HATsC5wNntFzLnMUDIo+Li4e2WYsGx9AgSUOWZMUzgA8CDwBvj1+44+BMYBmwV5IV27ZdjPrP0CBJQxSvCPlV6ktfv6/M0ytbLqlv4giRJwABeGfL5WgADA2SNFwfBnYGfsiK7vxx8gXq00cPTLJio7aLUX8ZGiRpSJKs2Ad4L3AHsH+Zp4+0XFLflXl6C/XVL5dgb8PYMTRI0hAkWbED9ZdpBexX5ul17VY0UB8FHgYOTbJi/baLUf8YGiRpwJKseALwXWAxcHSZp+e0XNJAlXlaUh+3sSHwjnarUT8ZGiRpgJKs2BQ4D9iGerjlj7Rb0dAcQ30BrsOSrFjSdjHqD0ODJA1IkhVbAt8HtgfOBg4Yx+MYVqbM02uoQ9Im1MdxaAwYGiRpAJKs2A74MbATdU/DvmWePtRuVUP3fuqxKN4bL8yljjM0SFKfxbMkLgCeCJwOvLrM0/varWr4yjz9LfVppYuoB7NSx4WqGpeByCT1RQiLgbvj0hKq6p42y+mSJCseR33mwN9RnyVxDHDUfPlJYmXipbKvBTYCdinz9KKWS9IcGBokTWZoWGXx4lN/CxwLbArcDLypzNNzWy1sRCRZcTDwr8AlwPPm4c80Y2NB2wVIUlfFMQj2A44Aknj3l4B/iIMcqfZF4A3AS4HDgbzdcrS67GmQNJk9DTNKsmIxsDuwN/A6YN340Peox2D4WVu1jbJ4YOilcfFZZZ5e0WY9Wj2GBkmTGRoelWRFALYCXgC8MM6fA6wTV7kH+Dpwgr/Vzy7JiiOpexkuB55f5undszxFI8bQIGmyeRYakqxYA9gS2BZ48pT5tsB6U57yR+pehe8AZ5d5etfwqu22+F6fA7ySegyHN43RZcHnBUODpMnGMDQkWbGA+vTHlYWCJwELp3nqPcBVwM+AnwA/Ba6ez2dDzFWSFZsAFwNbA0eUefrxlkvSKjA0SJqsw6EhnvK4HfUIjNv33N6W6Q/8vh24hvq0wGum3L7Zv4T7L8mK5wHnUx8P8tYyT7/UcklqyNAgabIRDw1JVqxJfR2H7VcybTbN024CruaxoeDaMk//OOia9VhJVryS+ieeNakvE/7VlktSA4YGSZONSGiIFzl6KpNDwXbxvpX9nPAQdRC4smf6NfDrMk/vGEbNWjVx5Mx/pw4O7wc+Ys/OaDM0SJpsSKEhnpmwCfBnU6YnUYeDrad56u3AFawIBRMB4boyTx8eRK0anCQrXgWcCSwBzgLeVubpbe1WpekYGiRN1ofQEAPBxtRnJWwJbNFze2tWBITF02ziEeA6JvcaXAlcWebprataj0ZbkhU7A9+mPlj1D8C7gLPsdRg9hgZpNcSj8TdjxRfiBsD61KfnrUd9Hv+CnukR4EHqK/5Nne6mPkr/np7bk+4b6rC7PaHh9kXrL3n2u06vYpuWULdx41mmzanfk7VneaU7qYNB7/SbiXmZp/f3tV0aaXF0zU8DB8a7fg58APivMk+Xt1WXJjM0SD3ieeSbsOKv4ummzRnuVWIfYoZQEef3U18kaWKnrlayvBb1l/k6cd47rQMsWvzAvesvPW7fpwI87d1nPXLf2gtXp503Azf2TMt6bt9AHQz+6F+SmirJipdTX/Tr2fGuEvgKdU/EJf6baZehQWMtdpMvBDaM0+Oov/A3Bx4/ZdoiTmvNstmHmfwluIx6wJ+7qP96vou6B2F5XHc5EFjxRd07X0jdRb+Y+i/5lc2n3hdW9/1oYtGD93PFp/cBYId3n3njvWsvuiu26e44v22W6dYyTx8cZI0abzG8vxZ4B7Bbz0M3UY+X8TNWHNdyrRfAGh5Dg0ZKkhXvAY4G/hSnO+P8Ieou/t5pOXXX/8SX7zo9txexIijMFgImVNT/Kd24kumGntu3tjW4T08IWlm4WEgdKCZCxcpuPzhlemDK8v1H/uDk5Ydc8I2Jiy2N3CmXml+SrHgK9XU+9gKez2PH29izzNPvDr2wecrQoJESQ8P7qI8RmGv3/wPAHT3Tn+L8JuqDrXqnm4CbPPqekTnlUpoqyYp1qa/98WzqM2y2Aw4s8/S3rRY2jxgapgghLAWoqmrHtmsZNttu29uuZdhsu21vu5auGeaBXJIkqcMMDZIkqRFDgyRJasTQIEmSGjE0SJKkRgwNkiSpEU+5lCRJjdjTIEmSGjE0SJKkRgwNkiSpEUODJElqxNAgSZIaMTRIkqRGxj40hBB2DSEsDSFcE0I4KYSw5krWeU9c57IQwvdCCJvH+48KIVwSp0tDCFUIYef42A9CCFf3PP7KYbdtNg3b/s9xnaUhhKN77l8QQjg5PndpCOElq7Ldts2x7Yf1/Hv4vxDCM3seG/fPff8Qwm097Tuh57GnhxAuiu3/VghhybDa1NQc2971/f34EMLvQwjTXt59uvdnDPb3ubS90/v70FVVNbYTdSi6BtghLn8dePOUdZ4CXAssiss58PGVbOvFwK97ln8AvLjtNs6x7XsAPwbWAdYEvgm8ND72VuD0eHsn4CogNNlu21Mf2r4bsLhnvV/Mo899f+Ckabb9I+AV8fbHgKPbbm8/2z5lvU7t7z01Px54eFXfny7v731oe2f39zamce9p2AW4saqqy+Pyl4DXTVknAGsBi0IIAVgfWLaSbe0HnDqoQgegSdufDpxfVdUDVVUtB74P/HV87HXASQBVVV0G3AY8q+F22zantldV9d9VVd0T17sA2GYINffLXD/3lQp179s2VVWdO8N229bPtndtf6eqqh9VVfWHGVaZ6f3p8v4+p7Z3fH8funEPDU8Aru9Z/h2wde8KVVVdBXw2rrcM2BE4vnedEMJawD489j+RE2M35udCCOv1ufa5mrXtwC+APUIIG4QQFgJ/2bPOdM9vst22zbXtvQ4Gzply3zh/7gB7xfadG0LYZRW227a+fO4d3d+bmOn96fL+3kTTdnRtfx+6cQ8NYdYVQtgY2BvYFtgK+A3w3imr7UndVXldz31vrKpqR+C5wHLgE32puH9mbXtVVd8HTqPugjsP+CV1W2Z6/qzbHQFzbXu9kRD2AA4ADuu5e9w/97OBpKqqnYGPAP8Rj12YN5873dzfm5jp/eny/t5Ek++CLu7vQzfuoeF6JqfJbYDfT1lnN+A3VVUti92VZwIvmrLOG4Gv9t5RVdXv4/wh4PMreU7bmrSdqqo+WVXVs6qqeglwA3DlLM9vtN2WzbXthBBeBJwApFVV3dLznLH+3KuqurWqqvvi7f+Jz90uzsf+c4+6uL83MdP70+X9vYkZ29Hh/X3oxj00XAg8IYSwQ1x+C/WBT71+Czw/hLB+XN4dmPjdixDCBvG+r/fctyCEsFnPNvYFLutz7XM1a9tDCGuEEDaNt7cADgJOjA9/k/rgKEIIOwGbAhc32e4ImFPbY3tPA/auqurqnueM/eceQtiyZ70dgYQ6VP8BuD6E8IrptjsC5vpvvsv7exMzvT9d3t+bmLYdHd/fh6/tIzEHPVH3JFxOfYbEl4EFwGvoOUIceD/1Xxu/pP6HtGHPYwcC35yyzcXU/wgvi885E9is7bauatupDwC9HFga2/LqnueuBXyF+ojjy4GXzbTdttva57afB9wCXNIzrT1PPvdj4v2XAD8HXtXz2E7UxwRcDfwnsF7bbe1n2+PjXd7fT6T+67mK8xOou9XPmen96Xlfury/z6Xtnd7fhz15aWxJktTIuP88IUmS+sTQIEmSGjE0SJKkRgwNkiSpEUODJElqxNAgSZIaMTRIkqRGDA2SJKkRQ4MkSWrE0CBJkhoxNEiSpEYMDZIkqRFDgyRJasTQIEmSGjE0SJKkRgwNkiSpEUODJElqxNAgSZIaMTRIkqRGDA2SJKkRQ4MkSWrE0CBJkhoxNEiSpEYMDZIkqZH/B1o0hSdikZcUAAAAAElFTkSuQmCC"></div></div></div></div></td>
    </tr>
    <tr id="table_low_2_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=1312000C0AAASAS&amp;denomIds=13.12&amp;selectedTab=summary" target="_blank">Aluminium chloride 20% solution : 419</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=1312000C0AAAWAW&amp;denomIds=13.12&amp;selectedTab=summary" target="_blank">Aluminium chloride 20% spray : 107</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=1312000C0BBAAAS&amp;denomIds=13.12&amp;selectedTab=summary" target="_blank">Anhydrol Forte 20% solution : 77</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=1312000C0BCAAAS&amp;denomIds=13.12&amp;selectedTab=summary" target="_blank">Driclor 20% solution : 88</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=1312000C0BDACAW&amp;denomIds=13.12&amp;selectedTab=summary" target="_blank">Odaban 20% spray : 18</a></li></ul></td></tr><tr class="row_4">
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0502050C0&amp;denomIds=5.2.5&amp;selectedTab=summary">Terbinafine hydrochloride</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_low_3_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>5932</td>
      <td>Other antifungals</td>
      <td>6061</td>
      <td>0.98</td>
      <td>0.99</td>
      <td>0.01</td>
      <td>-2.61</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_ykwV6swZR61VxNUyUypRRFkAEdLeRB7"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_ykwV6swZR61VxNUyUypRRFkAEdLeRB7" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAg0AAACWCAYAAABdJrs9AAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAAXEQAAFxEByibzPwAAADh0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uMy4xLjMsIGh0dHA6Ly9tYXRwbG90bGliLm9yZy+AADFEAAAPP0lEQVR4nO3dfbBc9V3H8fePJCSYhIdWnmKAo52OQjAtBbRAIEUpTyeltmTaDmILlmnHykwV6swZR61VxNU+yUypRRFkAEdLeRB7YOShUCYwVJ6DSam0cSkRKA9OKwTCU49/nN+l6zX33nPvnt1z9u77NbPzy909e873t3t/dz/5nYcNRVEgSZI0k52aLkCSJI0GQ4MkSarE0CBJkioxNEiSpEoMDZIkqRJDgyRJqsTQIEmSKjE0SJKkSgwNkiSpEkODJEmqxNAgSZIqMTRIkqRKDA2SJKkSQ4MkSarE0CBJkioxNEiSpEoMDZIkqRJDgyRJqsTQIEmSKjE0SJKkSgwNkiSpEkODJEmqxNAgjasQlhJCEW9Lmy5HUvsZGiRJUiULmy5AkmYjyfLjgbXAtd1Oem/T9UjjJBRF0XQNkppQ7pJ4If60jKLY1mQ5VSRZ/ings/HHAki7nfTGBkuSxoq7JySNhCTL3wqcB2wHvgAE4G+SLF/eaGHSGDE0SBoVfwwsBs7rdtJzgauAlcBpTRYljRNDg6TWS7L8zcB64EfAF+PdE+2ZjRQljSFDg6RR8GFgZ+Dybid9Md53N/Ad4JeTLP+FxiqTxoihQdIo+EBsL5m4o9tJC+Af448nD70iaQwZGiS1WpLl+wLvBB4DHpz08E2xPX6oRUljytAgqe1Oie11cXah178B/wMck2T5kuGWJY0fQ4OktjspttdPfqDbSV8DvgHsQjkbIWmADA2SWivJ8oXAscBLwJ1TLLYhtoYGacAMDZLa7DBgV+CObid9eYpl7o7tEcMpSRpfhgZJbXZcbG+ZZpn7gdeAdyZZHgZfkjS+DA2S2uyY2N421QLdTvoS5VkVewE/O4yipHFlaJDUSvF4hiMov1TroRkWvye2hwy0KGnMGRoktdVqYBlwdzxLYjoToWL1YEuSxpuhQVJbrYnthmmXKm2MraFBGiBDg6S2Oiq2VULDv8fW0CANkKFBUuvEsyDWAK8D35pp+W4nfR7YAvxckuXLB1yeNLYMDZLaKAFWAA92O+kLFZ8zsYvi4IFUJMnQIKmVZrNrYoLHNUgDZmiQ1EazOQhygqFBGjBDg6Q2mggNU33fxI4YGqQBMzRIapUky/cAVgFbup30yVk8dQvwIrDay0lLg2FokNQ2R8Z2Nrsm6HbS1ylPvdwVOKDuoiQZGiS1z1x2TUx4OLaraqpFUg9Dg6S2mctBkBM2x9bQIA2AoUFSayRZvhg4HPhv4JE5rGJTbA+qrShJbzA0SGqTQ4HFwF3dTvrjOTzfmQZpgAwNktqkn10TAFuB54EDkyz375tUMweVpDZZG9s5hYZuJy0oZxuWAvvXVZSkkqFBUiskWb4QOJryWgv39LEqj2uQBsTQIKktDgGWA3d2O+krfaxn4rgGQ4NUM0ODpLZ4V2xv63M9EzMNHgwp1czQIKktjo3t7X2ux5kGaUAMDZIaN+l4hnv7XN3jwAvAQX4HhVQvQ4OkNngHsAzY0O2kr/azop4zKJYB+9VQm6TI0CCpDeraNTHBizxJA2BokNQGJ8f2lprW52mX0gAYGiQ1KsnyNwFHAU8B99W0WmcapAEwNEhq2knAAuDrc/y+iR1xpkEaAEODpKati+2/1LjOx4FteAaFVCtDg6TGJFm+iHKm4WXg1rrWG2csNlNeYXJlXeuVxp2hQVKT1gC7Abd2O+m2mtftcQ1SzQwNkpr0vtjWuWtigleGlGpmaJDUiLhr4kPA68A1A9iE30Eh1czQIKkpxwF7Av/a7aRPD2D9zjRINTM0SGrKWbG9YkDrf4zyuyw8g0KqiaFB0tAlWb4SeC/wLHDtILYRz6D4NrArnkEh1cLQIKkJn6C8oNPF3U66fYDb2Rjbtw9wG9LYMDRIGqoky/cAzgZeBS4c8OYmLkt96IC3I40FQ4OkYTuX8qJLl3Y76dYBb8vQINXI0CBpaJIsP4AyNGwHzh/CJh+iPKXT0CDVwNAgaSjiGQxfAZYAn+120scGvc1uJ32J8noN+yZZvmLQ25PmO0ODpGE5GzgReAT48yFu110UUk0MDZIGLsnyY4EvAK8AvxFnAIbF0CDVZGHTBUia35IsPwK4nvLvzUe7nfTeIZcwsT1Dg9QnZxokDUyS5SdTfuX1MuAPu530kgbK2Eh5MORhDWxbmlcMDZIGIsnyD1POMOwCfKrbSc9roo6egyH3SbL8Z5qoQZovDA2Sapdk+bnAZUBBeQzD5xsu6e7YHtVoFdKI85gGSbWJp1WeB/w+5ZdFre920hubrQqAbwIfA9YCX224FmlkGRok1SLJ8p2ALwG/BfwQSLud9K5mq3rDHbFd22gV0ohz94SkvsUZhi9TBoYfAGtbFBiIl6veAqxKsnzPpuuRRpWhQVId/gT4OPAUcHS3k26cYfkm3BrbdzdahTTCDA2S+pJk+SeBPwB+BJzQ7aSPNlzSVG6IbdpoFdIIMzRImrMky08H/oryC6jWtXSGYcItlFekPDHJ8gVNFyONIkODpDlJsnwdcCnlhZPWdzvphoZLmla3k74A3A68CTim2Wqk0WRokDRrSZYfB3yN8gysM7udNG+4pKr+KbanNVqFNKIMDZJmJQaGfwYWA7/d7aSXN1zSbFxDuYtifZLlS5ouRho1hgZJlSVZfhZwI/BTwO91O+mXGy5pVrqd9IeUl7beHfhQw+VII8fQIGlGSZbvm2T5ZcDfUl4a+iPdTvq5hsuaqwtie068voSkirwipDSGkixfdtAZF/ziDX//SQB+6ROXnfl0lm8DXqY8E+Jl4DXgAOBY4NeAJcCTwGndTnp7E3XX5E7gHuBwYD1wVbPlSKMjFEXRdA2ShiDJ8r0pP/zXA8fu8sr2Bd/+4noADvzdr/HSztPu4n8e+ApwfpziH2lJlv8q5SmYjwEHxzMrJM3A0CDNY/GroN9HGRSO5ie7JJ9Zvn3b/Q9f8METAA49+4rPPLd094JyNmFxbBdRXuHxXuDmbid9cdj1D1KS5VcD7weupPwmTv8YSjMwNEjzSNxH/1ZgHXAqcGTPw08AV8fbhu5frFsCTPwPexlFsW2YtTYtyfI3Aw8A+1F+b8bvdDvpq81WJbWboUGqQfyw3h3Ydwe3pcDEAXcvAs/G2w8oP8ifBJ7qdtJX5rDdRcCBwDso99GfALylZ5HvU15P4Wrg7m4n/fEbj4SwlDEODQBJlh9M+Z0UewH3A39KOasydq+FVIWhQZpCkuUXAbtSfrC+QHnlwyU9tz0oP2z2ju3iPjf5DGWAeILyexy285ODEhcAu8Tt7gLsA6wEVsTHet1PeVrkdcB9U067GxoASLL8LcDlwBHxrlcoD5Y8q9tJtzRWmNRCnj0hTe09lDMFMykoZw6eovzQn3x7Pi4D5azDT8fb3pQf+ividlYAewKrK9ZXxG1uBu6jnGq/o9tJn6j4fAHdTvq9JMvXAKdQXrvhOGAN8HSjhUkt5ExDjxDCJoCiKFY1Xcsw2N/5zf7OX+PUV7C/beLFnSRJUiWGBkmSVImhQZIkVWJokCRJlRgaJElSJYYGSZJUiadcSpKkSpxpkCRJlRgaJElSJYYGSZJUiaFBkiRVYmiQJEmVGBokSVIl8zo0hBDeFULYFEL4bgjh4hDCgh0s85m4zKYQwqd77l8YQrg0PndTCOHo2ay3CX3295x438YQwp0hhLf3PHZ7COHREMKD8XbCsPo0nT77e0YI4bmePl3Y89jBIYT7Yp+vCyEsG1afptNnf/+op68PhRCKEMLb4mOte39DCBeEELaGEF6bZpkdvh4jOnb76e8ojt1++jtSY7fPvrZv3BZFMS9vlIHou8BB8eevAh+ZtMxJwF3AYmABcA1wTHzsLOAf4r9XA/8BhCrrHdH+/gqwtGe5B3qedzuwpuk+1tzfM4CLp1j3BuD4+O+/BD496v2dtNwa4Dstf3/XAPsAr8329Ri1sVtDf0dq7NbQ31Ebu3Pu6w7W0/i4nc8zDYcDTxRFsTn+/HfAqZOWORi4rSiKl4uieB24BfhgfOxU4GKAoig2As8Bh1RcbxP66m9RFN8oimJbXO5bwP5DqLkf/b6/OxRC2BvYvyiKm6ZZbxPq7O+vA1cMrNIaFEWxoSiKp6ZZZLrXY9TGbl/9HcGx2+/7u0NtHbs19rUV43Y+h4aVwOM9P38f2G/SMg8AJ4UQdgshLAHe27PMVM+vst4m9NvfXh8Hbph030VxeuxLIYTldRXdhzr6+57Yp5tCCIfPYr1NqOX9DSEsAtbz///4tO39ncl0r8eojd0qqtY+CmO3ipn6O0pjdyYz1t2mcTufQ0OYaYGiKG4BrqSc5rkZeBh4fYbnz7jehvTb33IlIZwEnAmc03P36UVRrAIOi8t/rp6S+9Jvf78OJEVRvA34M+DauP9zXr+/wMmUU5z/2XNfG9/fmUz3eoza2K1ixtpHaOxWMV1/R23szqRK3a0Zt/M5NDzO/01r+wNbJy9UFMXni6I4pCiKo4H/Ah6Z4fmV1tuAfvtLCOFI4EIgLYrimZ7nbI3tq8BfA0cOpAez01d/i6J4tiiKl+K/vxmf+/OxnZfvb3Q6cPmk57Tx/Z3JdK/HqI3dKqatfcTGbhVT9ncEx+5MqvxetmbczufQcC+wMoRwUPz5o5QHhr0hhLBTCGHP+O99gY8BF8WHr6E8oIoQwmpgT+D+KuttSF/9jX28Enh/URSP9jxnYQhhr57VfADYOLBeVNdvf1f0LLcKSIAtcd/j4yGE46dab0P6/X0mhLAb8G7KA60m7mvr+zuT6V6PURu7VUxZ+wiO3Sqm6++ojd2ZTPt72bpxO+wjL4d5ozyqeDPwPeASYCFwCvHIW2BRfHxTfMHX9Tx3EXAZ5VGtm4G106236b7W0N+bgWeAB3tuOwNLKX+pN1JOd18F7NV0X2vo7/nx/geBe4ATex5bTXl8wKPA9cDypvvab3/j478JXDPpvla+v5RhZytQxPZCymnYG6Z7PXpeh1Ebu/30dxTHbj/9Hamx209f42OtGrd+NbYkSapkPu+ekCRJNTI0SJKkSgwNkiSpEkODJEmqxNAgSZIqMTRIkqRKDA2SJKkSQ4MkSarE0CBJkioxNEiSpEoMDZIkqRJDgyRJqsTQIEmSKjE0SJKkSgwNkiSpEkODJEmqxNAgSZIqMTRIkqRKDA2SJKkSQ4MkSarE0CBJkioxNEiSpEoMDZIkqRJDgyRJquR/AXGYBegJM6/qAAAAAElFTkSuQmCC"></div></div></div></div></td>
    </tr>
    <tr id="table_low_3_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0502050C0AAAAAA&amp;denomIds=5.2.5&amp;selectedTab=summary" target="_blank">Terbinafine 250mg tablets : 5897</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0502050C0AAAEAE&amp;denomIds=5.2.5&amp;selectedTab=summary" target="_blank">Terbinafine 250mg/5ml oral solution : 6</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0502050C0AAAFAF&amp;denomIds=5.2.5&amp;selectedTab=summary" target="_blank">Terbinafine 250mg/5ml oral suspension : 29</a></li></ul></td></tr><tr class="row_5">
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0601040I0&amp;denomIds=6.1.4&amp;selectedTab=summary">Glucose</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_low_4_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>2461</td>
      <td>Treatment of hypoglycaemia</td>
      <td>3845</td>
      <td>0.64</td>
      <td>0.78</td>
      <td>0.06</td>
      <td>-2.52</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_rLpeJa4gigsonghyKIhSXgSieIAsl4Mg"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_rLpeJa4gigsonghyKIhSXgSieIAsl4Mg" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
    <tr id="table_low_4_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0601040I0AAADAD&amp;denomIds=6.1.4&amp;selectedTab=summary" target="_blank">Glucose 40% oral gel : 800</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0601040I0BBABAD&amp;denomIds=6.1.4&amp;selectedTab=summary" target="_blank">GlucoGel 40% gel original : 1467</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0601040I0BBAEAD&amp;denomIds=6.1.4&amp;selectedTab=summary" target="_blank">GlucoGel 40% gel berry : 43</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0601040I0BDAAAG&amp;denomIds=6.1.4&amp;selectedTab=summary" target="_blank">GSF-Syrup oral gel 18g sachets peppermint : 6</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0601040I0BDABAG&amp;denomIds=6.1.4&amp;selectedTab=summary" target="_blank">GSF-Syrup oral gel 18g sachets mixed : 5</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0601040I0BDACAG&amp;denomIds=6.1.4&amp;selectedTab=summary" target="_blank">GSF-Syrup oral gel 18g sachets orange : 3</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0601040I0BEAAAD&amp;denomIds=6.1.4&amp;selectedTab=summary" target="_blank">Dextrogel 40% gel : 88</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0601040I0BFAAAD&amp;denomIds=6.1.4&amp;selectedTab=summary" target="_blank">Rapilose 40% gel : 20</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0601040I0BGAAAD&amp;denomIds=6.1.4&amp;selectedTab=summary" target="_blank">GlucoBoost 40% gel : 29</a></li></ul></td></tr><tr class="row_6">
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0407020Q0&amp;denomIds=4.7.2&amp;selectedTab=summary">Morphine sulfate</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_low_5_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>29887</td>
      <td>Opioid analgesics</td>
      <td>218486</td>
      <td>0.14</td>
      <td>0.22</td>
      <td>0.04</td>
      <td>-2.30</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_isK2ooKI7solurK6wqK7UKjgoiigyKVI"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_isK2ooKI7solurK6wqK7UKjgoiigyKVI" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
    <tr id="table_low_5_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0407020Q0AAA6A6&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine sulfate 20mg/ml oral solution sugar free : 5</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0407020Q0AAABAB&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine sulfate 10mg/1ml solution for injection ampoules : 1061</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0407020Q0AAADAD&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine sulfate 30mg/1ml solution for injection ampoules : 23</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0407020Q0AAAFAF&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine sulfate 20mg/1ml solution for injection ampoules : 8</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0407020Q0AAAHAH&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine 100mg modified-release tablets : 85</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0407020Q0AAAIAI&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine 60mg modified-release tablets : 288</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0407020Q0AAAKAK&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine 10mg modified-release tablets : 3025</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0407020Q0AAALAL&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine 30mg modified-release tablets : 1255</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0407020Q0AAAMAM&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine sulfate 60mg/2ml solution for injection ampoules : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0407020Q0AACDCD&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine 10mg tablets : 1222</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0407020Q0AACECE&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine 20mg tablets : 305</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0407020Q0AACFCF&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine 15mg modified-release tablets : 780</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0407020Q0AACGCG&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine 5mg modified-release tablets : 1685</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0407020Q0AACNCN&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine sulfate 10mg/5ml oral solution : 7827</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0407020Q0AACPCP&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine 30mg modified-release granules sachets sugar free : 12</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0407020Q0AACVCV&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine 20mg modified-release granules sachets sugar free : 62</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0407020Q0AADCDC&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine 60mg modified-release granules sachets sugar free : 6</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0407020Q0AADDDD&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine 100mg modified-release granules sachets sugar free : 4</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0407020Q0AADRDR&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine 50mg tablets : 14</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0407020Q0AADUDU&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine 90mg modified-release capsules : 16</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0407020Q0AADVDV&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine 120mg modified-release capsules : 7</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0407020Q0AADWDW&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine 150mg modified-release capsules : 100</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0407020Q0AAEBEB&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine 100mg modified-release capsules : 11</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0407020Q0AAEFEF&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine 10mg modified-release capsules : 1667</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0407020Q0AAEGEG&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine 30mg modified-release capsules : 551</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0407020Q0AAEHEH&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine 60mg modified-release capsules : 178</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0407020Q0AAEIEI&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine 200mg modified-release capsules : 30</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0407020Q0AAFDFD&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine sulfate 500micrograms/5ml oral solution : 3</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0407020Q0AAFYFY&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine 0.2% in Intrasite gel : 32</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0407020Q0AAFZFZ&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine sulfate 5mg/5ml solution for injection ampoules : 3</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0407020Q0AAGAGA&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine sulfate 10mg/10ml solution for injection ampoules : 9</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0407020Q0BBAAAK&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">MST Continus 10mg tablets : 672</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0407020Q0BBABAL&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">MST Continus 30mg tablets : 306</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0407020Q0BBACAI&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">MST Continus 60mg tablets : 165</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0407020Q0BBADAH&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">MST Continus 100mg tablets : 15</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0407020Q0BBAEAG&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">MST Continus 200mg tablets : 9</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0407020Q0BBAFCV&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">MST Continus suspension 20mg granules sachets : 47</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0407020Q0BBAGCP&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">MST Continus suspension 30mg granules sachets : 7</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0407020Q0BBAKCG&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">MST Continus 5mg tablets : 288</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0407020Q0BBALCF&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">MST Continus 15mg tablets : 232</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0407020Q0BCABA6&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Oramorph 20mg/ml concentrated oral solution : 5</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0407020Q0BCAGCN&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Oramorph 10mg/5ml oral solution : 5168</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0407020Q0BHACCD&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Sevredol 10mg tablets : 706</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0407020Q0BHADCE&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Sevredol 20mg tablets : 298</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0407020Q0BHAFDR&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Sevredol 50mg tablets : 36</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0407020Q0BIAAEG&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">MXL 30mg capsules : 9</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0407020Q0BIAFEI&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">MXL 200mg capsules : 16</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0407020Q0BKAAEF&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Zomorph 10mg modified-release capsules : 867</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0407020Q0BKABEG&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Zomorph 30mg modified-release capsules : 561</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0407020Q0BKACEH&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Zomorph 60mg modified-release capsules : 101</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0407020Q0BKADEB&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Zomorph 100mg modified-release capsules : 18</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0407020Q0BNAAAK&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphgesic SR 10mg tablets : 43</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0407020Q0BNABAL&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphgesic SR 30mg tablets : 30</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0407020Q0BNACAI&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphgesic SR 60mg tablets : 5</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0407020Q0BNADAH&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphgesic SR 100mg tablets : 8</a></li></ul></td></tr><tr class="row_7">
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0603020T0&amp;denomIds=6.3.2&amp;selectedTab=summary">Prednisolone</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_low_6_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>61039</td>
      <td>Use of corticosteroids</td>
      <td>71325</td>
      <td>0.86</td>
      <td>0.89</td>
      <td>0.02</td>
      <td>-2.17</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_KEkHhRxOMSGkcimXkFuO0Eghku0W223O"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_KEkHhRxOMSGkcimXkFuO0Eghku0W223O" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
    <tr id="table_low_6_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0603020T0AAAAAA&amp;denomIds=6.3.2&amp;selectedTab=summary" target="_blank">Prednisolone 1mg tablets : 8348</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0603020T0AAABAB&amp;denomIds=6.3.2&amp;selectedTab=summary" target="_blank">Prednisolone 2.5mg tablets : 810</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0603020T0AAACAC&amp;denomIds=6.3.2&amp;selectedTab=summary" target="_blank">Prednisolone 5mg tablets : 43039</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0603020T0AAAFAF&amp;denomIds=6.3.2&amp;selectedTab=summary" target="_blank">Prednisolone 2.5mg gastro-resistant tablets : 2354</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0603020T0AAAGAG&amp;denomIds=6.3.2&amp;selectedTab=summary" target="_blank">Prednisolone 5mg gastro-resistant tablets : 3276</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0603020T0AAARAR&amp;denomIds=6.3.2&amp;selectedTab=summary" target="_blank">Prednisolone 25mg tablets : 449</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0603020T0AAATAT&amp;denomIds=6.3.2&amp;selectedTab=summary" target="_blank">Prednisolone 1mg gastro-resistant tablets : 205</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0603020T0AAAXAX&amp;denomIds=6.3.2&amp;selectedTab=summary" target="_blank">Prednisolone 20mg tablets : 119</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0603020T0AAAYAY&amp;denomIds=6.3.2&amp;selectedTab=summary" target="_blank">Prednisolone 15mg/5ml oral liquid : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0603020T0AABHBH&amp;denomIds=6.3.2&amp;selectedTab=summary" target="_blank">Prednisolone 5mg soluble tablets : 2104</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0603020T0AABKBK&amp;denomIds=6.3.2&amp;selectedTab=summary" target="_blank">Prednisolone 10mg tablets : 173</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0603020T0AABLBL&amp;denomIds=6.3.2&amp;selectedTab=summary" target="_blank">Prednisolone 5mg/5ml oral solution unit dose : 34</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0603020T0AABMBM&amp;denomIds=6.3.2&amp;selectedTab=summary" target="_blank">Prednisolone 10mg/ml oral solution sugar free : 70</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0603020T0AABNBN&amp;denomIds=6.3.2&amp;selectedTab=summary" target="_blank">Prednisolone 30mg tablets : 30</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0603020T0BLAAAB&amp;denomIds=6.3.2&amp;selectedTab=summary" target="_blank">Pevanti 2.5mg tablets : 14</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0603020T0BLABAC&amp;denomIds=6.3.2&amp;selectedTab=summary" target="_blank">Pevanti 5mg tablets : 13</a></li></ul></td></tr><tr class="row_8">
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=1404000H0&amp;denomIds=14.4&amp;selectedTab=summary">Influenza</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_low_7_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>190811</td>
      <td>Vaccines and antisera</td>
      <td>201114</td>
      <td>0.95</td>
      <td>0.97</td>
      <td>0.01</td>
      <td>-1.98</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_FQ1BC0FRdBAEBBX0yCgQtYzHBZcgR6LG"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_FQ1BC0FRdBAEBBX0yCgQtYzHBZcgR6LG" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
    <tr id="table_low_7_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=1404000H0AAAMAM&amp;denomIds=14.4&amp;selectedTab=summary" target="_blank">Adjuvanted trivalent flu vacc (SA, inact) inj 0.5ml pfs : 8462</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=1404000H0AAANAN&amp;denomIds=14.4&amp;selectedTab=summary" target="_blank">Adjuvanted quadrivalent flu vacc (SA, inact) inj 0.5ml pfs : 3000</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=1404000H0BCAAAF&amp;denomIds=14.4&amp;selectedTab=summary" target="_blank">Influvac Sub-unit vacc inj 0.5ml pre-filled syringes : 161</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=1404000H0BCADAF&amp;denomIds=14.4&amp;selectedTab=summary" target="_blank">Influvac sub-unit Tetra vacc inj 0.5ml pre-filled syringes : 27347</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=1404000H0BNAAAF&amp;denomIds=14.4&amp;selectedTab=summary" target="_blank">Imuvac vacc inj 0.5ml pre-filled syringes : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=1404000H0BUAAAK&amp;denomIds=14.4&amp;selectedTab=summary" target="_blank">Fluarix Tetra vacc inj 0.5ml pre-filled syringes : 5</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=1404000H0BWAAAK&amp;denomIds=14.4&amp;selectedTab=summary" target="_blank">Quadrivalent Flu/Vac/Split inj 0.5ml pfs : 17068</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=1404000H0BXAAAM&amp;denomIds=14.4&amp;selectedTab=summary" target="_blank">Fluad vacc inj 0.5ml pre-filled syringes : 40477</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=1404000H0BYAAAF&amp;denomIds=14.4&amp;selectedTab=summary" target="_blank">Influenza Tetra MYL vacc inj 0.5ml pre-filled syringes : 4062</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=1404000H0BZAAAF&amp;denomIds=14.4&amp;selectedTab=summary" target="_blank">Flucelvax Tetra vacc inj 0.5ml pre-filled syringes : 38748</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=1404000H0CCAAAN&amp;denomIds=14.4&amp;selectedTab=summary" target="_blank">Fluad Tetra vaccine inj 0.5ml pre-filled syringes : 50492</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=1404000H0CEAAAP&amp;denomIds=14.4&amp;selectedTab=summary" target="_blank">Supemtek Quadrivalent vaccine (recombinant) inj 0.5ml pfs : 988</a></li></ul></td></tr><tr class="row_9">
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0301030S0&amp;denomIds=3.1.3&amp;selectedTab=summary">Theophylline</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_low_8_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>3296</td>
      <td>Theophylline</td>
      <td>3847</td>
      <td>0.86</td>
      <td>0.94</td>
      <td>0.04</td>
      <td>-1.92</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_l4hExXZNFEkkoihkUDGKGktEjEuOEtcI"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_l4hExXZNFEkkoihkUDGKGktEjEuOEtcI" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
    <tr id="table_low_8_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0301030S0AAAMAM&amp;denomIds=3.1.3&amp;selectedTab=summary" target="_blank">Theophylline 200mg modified-release tablets : 225</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0301030S0AAAPAP&amp;denomIds=3.1.3&amp;selectedTab=summary" target="_blank">Theophylline 300mg modified-release tablets : 44</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0301030S0AAARAR&amp;denomIds=3.1.3&amp;selectedTab=summary" target="_blank">Theophylline 400mg modified-release tablets : 26</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0301030S0AABKBK&amp;denomIds=3.1.3&amp;selectedTab=summary" target="_blank">Theophylline 50mg/5ml oral solution : 2</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0301030S0AABLBL&amp;denomIds=3.1.3&amp;selectedTab=summary" target="_blank">Theophylline 50mg/5ml oral suspension : 6</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0301030S0BKAAAR&amp;denomIds=3.1.3&amp;selectedTab=summary" target="_blank">Uniphyllin Continus 400mg tablets : 438</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0301030S0BKABAM&amp;denomIds=3.1.3&amp;selectedTab=summary" target="_blank">Uniphyllin Continus 200mg tablets : 2187</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0301030S0BKACAP&amp;denomIds=3.1.3&amp;selectedTab=summary" target="_blank">Uniphyllin Continus 300mg tablets : 368</a></li></ul></td></tr><tr class="row_10">
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0&amp;denomIds=9.6.4&amp;selectedTab=summary">Colecalciferol</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_low_9_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>378281</td>
      <td>Vitamin D</td>
      <td>397332</td>
      <td>0.95</td>
      <td>0.97</td>
      <td>0.01</td>
      <td>-1.81</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_9CheEIebRZEINAJV0AqBtsBwFNEqouAp"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_9CheEIebRZEINAJV0AqBtsBwFNEqouAp" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
  <tr id="table_low_9_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0AAACAC&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 3,000unit tablets : 277</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0AAANAN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 800unit capsules : 29147</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0AAAUAU&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 15,000units/5ml oral suspension : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0AABABA&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 2,000unit capsules : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0AABFBF&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 600unit capsules : 78</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0AABGBG&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 1,000unit tablets : 13441</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0AABHBH&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 1,000unit capsules : 5722</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0AABIBI&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 400unit capsules : 2778</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0AABNBN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 5,000units/5ml oral solution : 4</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0AABSBS&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 400unit / Calcium carbonate 1.5g tablets : 1211</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0AABTBT&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 2,000units/ml oral drops sugar free : 327</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0AABUBU&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 200unit / Calcium carbonate 1.25g chew tab : 3013</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0AABWBW&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 400unit / Calcium carbonate 1.25g chew tab : 13580</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0AABXBX&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 440unit/Calcium carb 1.25g efferv gran sach : 492</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0AABYBY&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 400unit / Calcium carbonate 1.5g chewable tab : 54501</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0AABZBZ&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 800unit/Calcium phosphate 3.1g oral pdr sach : 217</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0AACBCB&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 400unit / Calcium carbonate 1.5g efferv tab : 4044</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0AACCCC&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 400unit / Calcium carbonate 1.25g tablets : 3</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0AACDCD&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 200unit / Calcium carbonate 750mg tablets : 5783</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0AACICI&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 400units/dose oral spray sugar free : 25</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0AACJCJ&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 800units/ml oral drops sugar free : 2</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0AACNCN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 5,000unit tablets : 35</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0AACPCP&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 2,200unit tablets : 2</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0AACQCQ&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 10,000unit tablets : 37</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0AACRCR&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 20,000unit tablets : 1106</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0AACSCS&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 800unit tablets : 17236</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0AACVCV&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 40,000unit capsules : 603</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0AACYCY&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 50,000unit tablets : 21</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0AADADA&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 200units/drop oral drops sugar free : 60</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0AADBDB&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 2,000unit tablets : 1627</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0AADDDD&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 2,000unit orodispersible tablets sugar free : 38</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0AADFDF&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 3,200unit capsules : 617</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0AADGDG&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 20,000units/ml oral solution : 2</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0AADHDH&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 25,000units/1ml soln ud amp sugar free : 20</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0AADIDI&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 880unit / Calcium carbonate 2.5g chew tab : 386</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0AADJDJ&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 500unit capsules : 3</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0AADKDK&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 25,000unit tablets : 70</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0AADLDL&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 800unit / Calcium carbonate 2.5g chewable tab : 81</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0AADNDN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 10,000units/ml oral drops sugar free : 95</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0AADPDP&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 10,000units/ml oral solution sugar free : 88</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0AADQDQ&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 2,400units/ml oral drops sugar free : 206</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0AADRDR&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 20,000unit capsules : 5046</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0AADSDS&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 15,000units/5ml oral solution : 10</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0AADTDT&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 2,740units/ml oral drops sugar free : 88</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0AADUDU&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 50,000units/1ml soln ud amp sugar free : 5</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0AADVDV&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 10,000unit capsules : 140</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0AADWDW&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 2,200unit capsules : 88</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0AADXDX&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 2,500unit capsules : 87</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0AADYDY&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 3,000unit capsules : 31</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0AAEAEA&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 5,000unit capsules : 44</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0AAEBEB&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 1,000unit / Calcium carbonate 2.5g chew tab : 282</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0AAECEC&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 4,000unit capsules : 2</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0AAEDED&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 1,000unit chewable tablets : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0AAEEEE&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 4,000unit tablets : 373</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0AAEJEJ&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 5,600unit capsules : 17</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0AAEKEK&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 25,000unit capsules : 58</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0AAELEL&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 400unit tablets : 1540</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0AAENEN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 15,000units/5ml oral solution sugar free : 5</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0AAEPEP&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 10,000units/5ml oral solution sugar free : 4</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0AAEQEQ&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 50,000unit capsules : 52</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0AAETET&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 400units/ml oral drops sugar free : 153</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0AAFCFC&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 2,500units/ml oral drops sugar free : 2</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0AAFGFG&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 200units/drop oral drops : 905</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0BEAADW&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Solgar Vitamin D3 2,200unit capsules : 19</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0BEABBF&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Solgar Vitamin D3 600unit capsules : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0BEACBG&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Solgar Vitamin D3 1,000unit tablets : 83</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0BEADBH&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Solgar Vitamin D3 1,000unit capsules : 49</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0BEAEBI&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Solgar Vitamin D3 400unit capsules : 16</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0BHAABN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">BabyD 1,000units/ml oral solution : 57</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0BIAABI&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Pro D3 400unit capsules : 162</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0BIABBH&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Pro D3 1,000unit capsules : 430</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0BIACDX&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Pro D3 2,500unit capsules : 53</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0BIADDV&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Pro D3 10,000unit capsules : 31</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0BIAEDR&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Pro D3 20,000unit capsules : 25</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0BIAGBT&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Pro D3 2,000units/ml liquid drops : 40</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0BIAICU&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Pro D3 2,000units/ml liquid : 37</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0BIAJAN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Pro D3 800unit capsules : 8</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0BIALDF&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Pro D3 3,200unit Vegan capsules : 2</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0BKAABS&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Accrete D3 tablets : 7487</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0BKABDI&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Accrete D3 One a Day 1000mg/880unit chewable tablets : 365</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0BMAABG&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Valupak Vitamin D3 1,000unit tablets : 5307</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0BMABBH&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Valupak Vitamin D3 1,000unit capsules : 349</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0BNAABY&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Adcal-D3 chewable tablets tutti frutti : 46840</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0BNABBY&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Adcal-D3 Lemon chewable tablets : 9445</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0BNACCB&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Adcal-D3 Dissolve 1500mg/400unit effervescent tablets : 3380</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0BNADCD&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Adcal-D3 750mg/200unit caplets : 26548</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0BPAABX&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Cacit D3 effervescent granules sachets : 282</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0BQAABW&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Calceos 500mg/400unit chewable tablets : 10580</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0BRAABU&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Calcichew D3 chewable tablets : 4035</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0BRABBW&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Calcichew D3 Forte chewable tablets : 6495</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0BRADDL&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Calcichew D3 1000mg/800unit Once Daily chewable tablets : 246</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0BSAABZ&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Calfovit D3 oral powder sachets : 286</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0BUAABY&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Natecal D3 600mg/400unit chewable tablets : 99</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0BWAABG&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 1,000unit tablets : 662</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0BWABCQ&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 10,000unit tablets : 25</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0BWACCR&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 20,000unit tablets : 133</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0BWAEDB&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 2,000unit tablets : 183</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0BWAFCN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 5,000unit tablets : 2</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0BWAGAC&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 3,000unit tablets : 38</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0BWAHEP&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 2,000units/ml oral solution : 4</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0BWAIBT&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 2,000units/ml oral drops : 23</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0BWAJEL&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 400unit tablets : 103</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0BWAKCS&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 800unit tablets : 224</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0BWALBI&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 400unit capsules : 23</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0BWAMDW&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 2,200unit capsules : 9</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0BWANDF&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 3,200unit capsules : 36</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0BWAPDV&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 10,000unit capsules : 60</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0BWAQEQ&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 50,000unit capsules : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0BWAREN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 15,000units/5ml oral solution : 4</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0BWASEN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 3,000units/ml oral solution : 10</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0BWAUAN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 800unit capsules : 383</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0BWAVDX&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 2,500unit capsules : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0BWAWDK&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 25,000unit tablets : 2</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0BWAXCV&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 40,000unit capsules : 71</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0BWAZBG&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 1,000unit Vegan tablets : 8</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0BWBABH&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 1,000unit capsules : 166</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0BWBBDR&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 20,000unit capsules : 151</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0BXAAAN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Fultium-D3 800unit capsules : 10833</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0BXABDF&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Fultium-D3 3,200unit capsules : 439</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0BXACDR&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Fultium-D3 20,000unit capsules : 3123</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0BXADDT&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Fultium-D3 2,740units/ml oral drops : 88</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0BZAACI&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">DLux 400 oral spray : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0CCAADS&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Pro D3 forte 3,000units/ml liquid : 36</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0CEAAAN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Bio-Vitamin D3 800unit capsules : 198</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0CEABBH&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Bio-Vitamin D3 1,000unit capsules : 47</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0CEACEA&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Bio-Vitamin D3 5,000unit capsules : 31</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0CEADDR&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Bio-Vitamin D3 20,000unit capsules : 15</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0CGAADR&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Hux D3 20,000unit capsules : 1945</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0CGABDF&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Hux D3 3,200unit capsules : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0CHAAEL&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Aciferol D3 400unit tablets : 34</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0CHABBG&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Aciferol D3 1,000unit tablets : 65</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0CHACCP&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Aciferol D3 2,200unit tablets : 30</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0CHADAC&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Aciferol D3 3,000unit tablets : 14</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0CHAFCQ&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Aciferol D3 10,000unit tablets : 2</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0CHAGCR&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Aciferol D3 20,000unit tablets : 4</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0CHAIEQ&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Aciferol D3 50,000unit capsules : 2</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0CHAJDS&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Aciferol D3 3,000units/ml liquid : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0CHAKCU&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Aciferol D3 2,000units/ml liquid : 9</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0CIAKCR&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">E-D3 20,000unit tablets : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0CJAACS&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Desunin 800unit tablets : 14773</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0CJABEE&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Desunin 4,000unit tablets : 78</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0CNACDR&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Plenachol D3 20,000unit capsules : 422</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0CNADCV&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Plenachol D3 40,000unit capsules : 159</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0CRAABG&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">BioLife Vitamin D3 1,000unit tablets : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0CVAADR&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">OsteoCaps D3 20,000unit capsules : 102</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0CVABBH&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">OsteoCaps D3 1,000unit capsules : 2096</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0CWAABY&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Evacal D3 1500mg/400unit chewable tablets : 18793</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0CYAADA&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">HealthAid Vitamin D3 200units/drop oral drops : 58</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0DBAACN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Vitamin D3 High Strength 5,000unit tablets : 3</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0DCABDD&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Vitamin D3 Lemon Melts 2,000unit tablets : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0DDAADS&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Kora LiquiD 3000units/ml oral solution : 21</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0DFAADH&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">InVita D3 25,000units/1ml oral solution : 116</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0DFABDQ&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">InVita D3 2,400units/ml oral drops : 55</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0DFACDU&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">InVita D3 50,000units/1ml oral solution : 22</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0DFADAN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">InVita D3 800unit capsules : 633</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0DFAEBI&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">InVita D3 400unit capsules : 65</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0DFAFEQ&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">InVita D3 50,000unit capsules : 19</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0DFAGEK&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">InVita D3 25,000unit capsules : 10</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0DFAHEJ&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">InVita D3 5,600unit capsules : 2</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0DGAADI&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">TheiCal-D3 1000mg/880unit chewable tablets : 24553</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0DHAABG&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Stexerol-D3 1,000unit tablets : 3564</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0DHABDK&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Stexerol-D3 25,000unit tablets : 269</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0DIAADN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Thorens 10,000units/ml oral drops : 440</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0DIABDP&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Thorens 25,000units/2.5ml oral solution : 92</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0DIACEK&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Thorens 25,000unit capsules : 8</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0DKAFET&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Vitamin D3 400units/ml for infants and children dps : 5</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0DMAAEB&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Calci-D 1000mg/1,000unit chewable tablets : 3854</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0DNAAAN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Strivit-D3 800unit capsules : 17</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0DPAAAN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">ColeKal-D3 800unit capsules : 3</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0DPABCS&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">ColeKal-D3 800unit tablets : 76</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0DPACDF&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">ColeKal-D3 3,200unit capsules : 6</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0DPADBH&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">ColeKal-D3 1,000unit capsules : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0DPAFBI&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">ColeKal-D3 400unit capsules : 3</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0DPAGBG&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">ColeKal-D3 1,000unit tablets : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0DPAJEL&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">ColeKal-D3 400unit tablets : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0DPAKCV&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">ColeKal-D3 40,000unit capsules : 4</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0DTACEL&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">FSC Vitamin D3 400unit tablets : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0DZAABU&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 200unit with Calcium 500mg chewable tablets : 8</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0DZABBW&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 400unit with Calcium 500mg chewable tablets : 4</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0DZADBY&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 400unit with Calcium 600mg chewable tablets lemon : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0ECACDF&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">ColeDose D3 3,200unit capsules : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0ECAHAN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">ColeDose D3 800unit capsules : 3</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0ECAIDB&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">ColeDose D3 2,000unit tablets : 3</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0ECAKCR&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">ColeDose D3 20,000unit tablets : 4</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0ECAMDR&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">ColeDose D3 20,000unit capsules : 18</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=72Q&amp;numIds=0906040G0ECAPEQ&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">ColeDose D3 50,000unit capsules : 1</a></li></ul></td></tr></tbody></table>
        </div>
      </div>
    </section>

    <script
      crossorigin="anonymous"
      integrity="sha512-pax4MlgXjHEPfCwcJLQhigY7+N8rt6bVvWLFyUMuxShv170X53TRzGPmPkZmGBhk+jikR8WBM4yl7A9WMHHqvg=="
      referrerpolicy="no-referrer"
      src="https://cdnjs.cloudflare.com/ajax/libs/bootstrap/5.1.3/js/bootstrap.bundle.min.js"
    ></script>
    <script>
      var tooltipTriggerList = [].slice.call(
        document.querySelectorAll('[data-bs-toggle="tooltip"]')
      );
      var tooltipList = tooltipTriggerList.map(function (tooltipTriggerEl) {
        return new bootstrap.Tooltip(tooltipTriggerEl);
      });
    </script>

    <script>
      ["higherHeading-lowShowHide", "lowerHeading-lowShowHide"].forEach(function (
        btn
      ) {
        var toggleButton = document.getElementById(btn);
        var section = toggleButton.closest("section");
        toggleButton.addEventListener("click", function (e) {
          var lowRows = section.querySelectorAll("tr.low_number");
          lowRows.forEach(function (row) {
            return row.classList.toggle("d-none");
          });

          if (toggleButton.textContent === "Hide low numbers") {
            toggleButton.textContent = "Show low numbers";
            toggleButton.classList.remove("btn-outline-danger");
            toggleButton.classList.add("btn-outline-success");
          } else {
            toggleButton.textContent = "Hide low numbers";
            toggleButton.classList.remove("btn-outline-success");
            toggleButton.classList.add("btn-outline-danger");
          }
        });
      });
    </script>

    <script>
      var explainerTextCollapse = document.getElementById("explainerTextCollapse");
      var explainerTextBtn = document.getElementById("explainerTextBtn");
      explainerTextCollapse.addEventListener("hidden.bs.collapse", function () {
        explainerTextBtn.textContent = "Show more +";
      });
      explainerTextCollapse.addEventListener("shown.bs.collapse", function () {
        explainerTextBtn.textContent = "Show less -";
      });
    </script>
</body>

</html>